data_2ju3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ju3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.61 ' CG ' HD11 ' A' ' 127' ' ' ILE . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' NE2' ' HE3' ' A' ' 125' ' ' LYS . 34.4 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' HD1' HD13 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.931 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.931 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.576 HG13 ' HG3' ' A' ' 20' ' ' LYS . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.845 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.845 HD11 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.959 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.959 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.708 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.669 HG21 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.564 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.469 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 27.6 t-80 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.714 HG21 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' CD2' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.519 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.644 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.632 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.061 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.036 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.743 ' HB3' ' C ' ' A' ' 102' ' ' THR . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.061 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.831 HG23 ' HB ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 1.039 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.743 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.036 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.717 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.583 HG22 ' HD3' ' A' ' 121' ' ' LYS . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.87 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 1.039 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.629 HD13 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.87 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.564 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HE3' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.657 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.722 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.505 ' CG ' HD13 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.8 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.786 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.598 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.431 HE21 HG12 ' A' ' 9' ' ' VAL . 80.2 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.754 ' HD1' HD13 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.795 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 29' ' ' ILE . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.888 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.888 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.786 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.889 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.635 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.968 ' HG2' HG21 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.693 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.889 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 HD11 HD13 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.533 HD13 HD22 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.589 HG21 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' LYS . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.968 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.767 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.767 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.762 HG13 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.626 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.93 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.082 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.93 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.829 HG23 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.733 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.851 HG21 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.762 ' HG3' HG13 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.851 ' HG3' HG21 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.829 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.543 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.082 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.01 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.925 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.885 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.611 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.754 HD13 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.607 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.723 ' HE3' HG22 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.885 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.925 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.722 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 1.022 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.715 ' HG3' HD13 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' N ' HD11 ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.104 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.58 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.58 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.684 ' HD1' HD13 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.804 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.438 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.804 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 29' ' ' ILE . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.836 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.836 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 1.104 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 1.022 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' CD2' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.688 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HB3' HD13 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 58' ' ' VAL . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.688 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.656 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' ' HD3' ' A' ' 80' ' ' LYS . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt . . . . . 0 N--CA 1.432 -1.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.777 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.656 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.107 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.013 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.788 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.107 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.855 HG23 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.777 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.534 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.788 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.013 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.686 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.781 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.2 t-20 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.579 ' HB ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.889 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.684 HD13 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.889 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.781 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.628 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.494 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 4.4 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.111 0.482 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.645 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.49 ' N ' HD11 ' A' ' 127' ' ' ILE . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.593 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.66 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HD1' HD13 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.778 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.778 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.727 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.609 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.727 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 35' ' ' ILE . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.785 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG13 ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.646 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.785 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.781 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.781 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.645 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.452 ' CA ' HG21 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.419 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 42.4 t-80 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.752 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.433 -1.292 0 CA-C-O 121.366 0.603 . . . . 0.0 111.704 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 96' ' ' LYS . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 94' ' ' THR . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.678 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.011 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.068 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.778 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.011 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.856 HG23 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.678 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' H ' HG13 ' A' ' 79' ' ' VAL . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.068 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.499 ' N ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 1.121 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.4 t-20 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.591 ' HB ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.885 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.667 HD13 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.885 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.633 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.479 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 1.121 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.433 0.635 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.2 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.616 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HD1' HD13 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.829 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.829 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.684 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 26.8 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.672 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.864 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 1.012 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.864 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.653 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.808 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.808 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.719 HG13 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.728 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.007 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.018 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.688 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.007 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.863 HG23 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.7 ' HB ' HG21 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.461 ' H ' HG13 ' A' ' 79' ' ' VAL . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 HD21 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.863 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.018 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.613 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.775 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.572 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.677 HD13 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.775 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.609 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 122.241 1.02 . . . . 0.0 113.073 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.732 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' HD1' HD13 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.783 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.783 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 36' ' ' LYS . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.692 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.831 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.831 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.678 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.08 HD13 ' HE3' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.678 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.65 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.713 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 120.982 0.42 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.742 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.008 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.0 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.08 ' HE3' HD13 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.806 HG23 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 1.015 HG21 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.491 HG21 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 1.015 ' HG3' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.806 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.618 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.008 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.0 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.554 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.463 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 21.4 t-20 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.932 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.573 HD13 ' HD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.932 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.68 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.674 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.953 ' HB2' HG11 ' A' ' 42' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.566 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.667 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' HD13 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.895 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.895 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.873 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.873 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.781 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.953 HG11 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.752 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB3' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.752 HG23 ' HB2' ' A' ' 43' ' ' HIS . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.696 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.625 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 59' ' ' ILE . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.821 HG21 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.468 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.53 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.535 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.822 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 121.0 0.429 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.757 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.02 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.814 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.02 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.753 HG23 ' HB ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.815 HG21 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' H ' HG13 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.815 ' HG3' HG21 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.753 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.743 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.761 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.694 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 1.05 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.751 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.623 ' HB ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.865 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.66 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.865 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.751 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 1.05 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.698 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.814 ' HB2' HG11 ' A' ' 42' ' ' VAL . 89.1 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.967 0.889 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.576 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.734 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.646 ' HD1' HD13 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.812 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.812 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 24' ' ' LEU . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.598 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.804 ' HG2' HG21 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.675 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.849 HD13 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.849 HG13 HD13 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.662 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HG21 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.675 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.596 ' CD2' ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.73 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 37.9 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.73 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.678 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.51 ' HG2' HD11 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.072 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.097 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.721 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.072 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.678 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.554 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.618 HD11 ' HE3' ' A' ' 113' ' ' MET . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.709 ' HA ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.721 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.097 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.551 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.898 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 1.125 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.618 ' HE3' HD11 ' A' ' 98' ' ' ILE . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 1.125 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.898 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.711 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.607 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.871 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB2' HG21 ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 34.7 m-20 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.589 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.696 ' HD1' HD13 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.85 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.85 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 ' HG3' ' A' ' 20' ' ' LYS . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.867 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.867 HD11 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.711 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 64' ' ' THR . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' HE2' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.698 HG21 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.698 HG22 HG21 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 59' ' ' ILE . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.817 HG21 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.735 HD13 ' HE1' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.907 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.907 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.355 0.598 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.713 HG13 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 94' ' ' THR . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.813 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.758 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 103' ' ' GLU . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.813 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.76 HG23 ' HB ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.871 HG21 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.67 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.713 ' H ' HG13 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.829 HD11 ' HE1' ' A' ' 113' ' ' MET . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.871 ' HG3' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.412 ' O ' HG11 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.913 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.894 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 105' ' ' ASN . 0.2 OUTLIER -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.62 ' HB ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.829 ' HE1' HD11 ' A' ' 98' ' ' ILE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.732 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.732 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.871 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.581 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.706 ' HB2' HG11 ' A' ' 42' ' ' VAL . 27.2 p . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.848 0.833 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.62 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.523 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.8 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.622 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.707 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.776 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.776 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.811 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.702 HG23 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HG2' HG21 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.728 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.509 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 40.3 t-80 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.665 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.896 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.896 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.118 0.485 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.786 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.665 ' HG2' HD11 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 1.06 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.932 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.886 HG23 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.786 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.683 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.683 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 1.048 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.886 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.923 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.932 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.477 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.8 OUTLIER -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG ' ' A' ' 7' ' ' TYR . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.579 ' HB ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 1.048 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.662 HD13 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.707 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.62 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.263 0.554 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -104.57 96.44 6.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.763 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.495 ' HE2' ' HG3' ' A' ' 126' ' ' ARG . 18.0 t80 -137.63 39.95 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.563 . . . . 0.0 109.789 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m -48.85 137.06 13.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.61 ' CG ' HD11 ' A' ' 127' ' ' ILE . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.436 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' NE2' ' HE3' ' A' ' 125' ' ' LYS . 34.4 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.663 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' HD1' HD13 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.931 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.931 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.576 HG13 ' HG3' ' A' ' 20' ' ' LYS . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.845 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.845 HD11 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.959 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.959 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.708 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.669 HG21 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.564 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HG3' ' HE3' ' A' ' 74' ' ' MET . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.469 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 27.6 t-80 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.714 HG21 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' CD2' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.519 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.644 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -102.57 119.59 39.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.0 p -89.73 172.66 8.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.135 0.493 . . . . 0.0 111.535 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.65 ' HE3' ' HG3' ' A' ' 57' ' ' LYS . 26.1 ptm -68.98 -2.69 10.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.965 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.4 p -97.34 -17.93 19.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.583 0.706 . . . . 0.0 109.161 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.92 57.93 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.806 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -75.82 114.1 14.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.122 0.963 . . . . 0.0 110.833 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp -110.19 127.21 54.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.72 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.632 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.061 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -80.59 109.47 15.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.701 ' HB3' HG21 ' A' ' 92' ' ' VAL . 28.6 tt0 -124.4 142.48 51.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.558 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.91 55.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -165.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.4 -30.61 0.17 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 113.6 -1.3 . . . . 0.0 112.745 167.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.036 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 -99.78 -34.99 9.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.743 ' HB3' ' C ' ' A' ' 102' ' ' THR . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.061 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.831 HG23 ' HB ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 1.039 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.743 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.036 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.717 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.583 HG22 ' HD3' ' A' ' 121' ' ' LYS . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.87 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 1.039 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.629 HD13 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.87 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.564 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HE3' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.495 ' HG3' ' HE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.289 0.566 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -105.32 115.79 30.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.113 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -136.14 39.47 2.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.657 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t -39.85 138.36 0.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.722 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' CG ' HD13 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.8 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.786 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.598 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.431 HE21 HG12 ' A' ' 9' ' ' VAL . 80.2 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.754 ' HD1' HD13 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.795 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.795 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 29' ' ' ILE . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.888 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.888 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.717 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.717 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.786 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.657 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.889 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.635 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.968 ' HG2' HG21 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.693 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.889 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 HD11 HD13 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.533 HD13 HD22 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.589 HG21 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' LYS . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.693 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.968 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.767 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 -103.2 137.74 40.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.476 ' CG2' ' HE3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -107.39 177.5 4.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 172.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.409 ' HE1' ' HG3' ' A' ' 57' ' ' LYS . 37.3 tpp -72.5 -0.74 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.878 0.847 . . . . 0.0 110.045 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.4 p -88.82 -3.31 58.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.77 -11.82 38.65 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.276 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.57 118.77 23.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.001 0.905 . . . . 0.0 110.266 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.767 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? -106.18 124.34 49.44 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.333 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.762 HG13 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.626 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.93 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt -79.29 136.12 36.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.57 145.17 24.65 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.01 7.45 1.18 Allowed Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -159.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -84.6 -67.12 0.82 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.84 0.32 . . . . 0.0 110.813 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.082 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 -150.12 -40.85 0.13 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.01 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.93 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.829 HG23 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.733 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.851 HG21 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.762 ' HG3' HG13 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.851 ' HG3' HG21 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.829 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.543 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.082 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.01 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.925 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.401 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.885 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.611 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.754 HD13 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.607 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.723 ' HE3' HG22 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.885 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.925 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.722 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.877 0.37 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.48 113.35 23.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -134.15 -45.37 0.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.142 -0.349 . . . . 0.0 110.846 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 1.022 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p 58.66 112.49 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 174.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.715 ' HG3' HD13 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' N ' HD11 ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.104 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.58 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.58 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.684 ' HD1' HD13 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.804 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.438 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.804 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 29' ' ' ILE . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.836 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.836 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 1.104 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 1.022 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' CD2' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.688 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HB3' HD13 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 58' ' ' VAL . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.688 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.656 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' ' HD3' ' A' ' 80' ' ' LYS . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 -95.89 122.71 38.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -86.28 174.82 8.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.97 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 ptp -70.42 -2.0 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 p -97.08 -9.03 28.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.2 70.54 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.025 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -81.58 127.55 32.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.41 0.624 . . . . 0.0 110.437 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt -110.01 134.27 52.31 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.304 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.777 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.656 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.107 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp -79.99 132.65 36.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -93.33 144.85 24.93 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.54 82.73 0.08 OUTLIER Glycine 0 CA--C 1.498 -1.012 0 O-C-N 123.982 0.801 . . . . 0.0 114.356 -165.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -159.07 -73.01 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.105 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.013 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 -149.95 -36.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -171.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.788 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.107 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.855 HG23 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.777 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.534 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.855 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.788 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.013 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.686 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.781 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.2 t-20 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.579 ' HB ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.889 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.684 HD13 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.889 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.781 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.628 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.494 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -104.17 95.04 5.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.43 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -101.54 45.56 0.96 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.694 0.759 . . . . 0.0 110.186 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 4.4 m -62.12 144.67 55.02 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.166 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.645 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.49 ' N ' HD11 ' A' ' 127' ' ' ILE . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.593 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.667 ' HD1' HD13 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.778 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.778 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.727 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.609 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.727 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 35' ' ' ILE . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.785 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG13 ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.646 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.785 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.781 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.781 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.645 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.452 ' CA ' HG21 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HG3' ' HE3' ' A' ' 74' ' ' MET . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.419 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 42.4 t-80 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.665 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.752 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.56 131.88 52.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 p -94.58 179.01 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.429 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.557 ' HE3' ' HG3' ' A' ' 57' ' ' LYS . 32.7 tpp -78.94 -1.88 37.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.448 0.642 . . . . 0.0 110.203 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 p -94.75 -6.05 43.95 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.54 -28.8 7.86 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.553 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -72.57 116.16 12.7 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.706 0.765 . . . . 0.0 110.98 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -101.29 142.91 32.02 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.704 177.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 96' ' ' LYS . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.743 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 94' ' ' THR . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.678 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.011 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp -79.77 135.28 36.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 88' ' ' ASP . 28.2 tt0 -91.8 145.76 24.3 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.6 78.94 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.782 0 CA-C-O 122.071 0.817 . . . . 0.0 113.926 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 86' ' ' GLU . 7.7 t0 -158.7 -74.07 0.08 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.113 -1.543 . . . . 0.0 108.817 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.068 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 -154.32 -35.87 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -171.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.778 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.011 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.856 HG23 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.678 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.46 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' H ' HG13 ' A' ' 79' ' ' VAL . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.068 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.499 ' N ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 1.121 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.4 t-20 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.591 ' HB ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.885 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.667 HD13 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.885 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.633 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.479 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.842 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 1.121 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.371 0.605 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.26 110.69 22.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.888 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -101.51 44.73 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.188 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m -69.7 126.05 28.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.582 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.413 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.2 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.616 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HD1' HD13 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.829 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.829 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.684 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 26.8 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.672 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.672 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.932 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.864 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 1.012 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.864 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.618 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.653 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 74' ' ' MET . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.587 HD23 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.808 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 -110.74 128.22 55.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 75' ' ' THR . 34.6 p -89.27 166.23 13.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB3' HD13 ' A' ' 59' ' ' ILE . 21.8 ptm -65.07 -1.85 2.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.358 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 73' ' ' THR . 34.9 p -95.77 -22.13 17.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.7 -17.7 13.39 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.043 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.579 ' HB2' ' HZ3' ' A' ' 96' ' ' LYS . 8.0 mp0 -79.35 121.05 24.65 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.128 0.966 . . . . 0.0 112.104 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt -112.22 135.36 52.99 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.111 -1.858 . . . . 0.0 110.582 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.808 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.719 HG13 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.728 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.007 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -83.0 133.61 35.09 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 88' ' ' ASP . 27.4 tt0 -93.94 145.47 24.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.42 78.36 0.06 OUTLIER Glycine 0 CA--C 1.502 -0.747 0 O-C-N 124.088 0.868 . . . . 0.0 114.046 -169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 86' ' ' GLU . 6.2 t70 -159.4 -72.19 0.08 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.332 -1.434 . . . . 0.0 109.213 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.018 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 -153.41 -35.7 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -171.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.688 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.007 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.863 HG23 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.7 ' HB ' HG21 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.45 HG22 ' HG3' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 77' ' ' GLU . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 HD21 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.863 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.018 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.613 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.775 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.572 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.677 HD13 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.775 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.609 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -104.61 94.64 5.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.095 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.01 -66.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p 54.41 108.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.073 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.564 ' O ' HG11 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.732 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' HD1' HD13 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.783 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.783 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.553 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 36' ' ' LYS . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.692 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.831 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.77 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HG2' ' HG3' ' A' ' 74' ' ' MET . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 74' ' ' MET . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.77 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.831 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.678 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.08 HD13 ' HE3' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.678 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.65 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.713 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 -101.43 129.81 47.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -90.5 -173.75 3.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.072 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.531 ' HG3' ' HG2' ' A' ' 57' ' ' LYS . 50.3 ttm -73.02 -7.59 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.152 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.2 p -95.06 -11.63 27.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.317 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.08 -20.14 50.68 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.138 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.55 126.5 30.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 110.41 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt -109.4 139.02 44.89 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.249 -175.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.742 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -82.43 107.0 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 92' ' ' VAL . 25.9 tt0 -126.88 143.57 51.23 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.313 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.51 0.3 40.19 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -168.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 78.82 -39.12 0.23 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 113.398 -1.401 . . . . 0.0 112.429 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.008 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 -100.4 -30.27 11.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.564 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.0 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.08 ' HE3' HD13 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.806 HG23 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.704 ' HB ' HG21 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 1.015 HG21 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.491 HG21 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 1.015 ' HG3' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.806 ' HB ' HG23 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.618 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.008 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.0 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.554 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.463 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 21.4 t-20 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.932 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.573 HD13 ' HD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.932 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.68 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.711 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.674 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.03 0.443 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -78.97 89.6 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -71.46 74.87 0.77 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.155 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.953 ' HB2' HG11 ' A' ' 42' ' ' VAL . 2.1 t -107.92 142.01 38.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 172.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.566 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.667 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' HD13 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.895 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.895 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.713 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.873 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.873 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.781 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.953 HG11 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.752 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB3' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.752 HG23 ' HB2' ' A' ' 43' ' ' HIS . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.696 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.625 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 59' ' ' ILE . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.667 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.821 HG21 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.468 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.53 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.822 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 -113.44 118.54 34.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 p -89.62 -177.96 5.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 112.137 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.4 ttm -72.0 -3.6 23.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.413 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.7 p -96.44 -6.95 36.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.714 0.768 . . . . 0.0 109.481 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.97 -27.26 5.56 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.468 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.94 114.15 17.64 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.822 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt -109.64 141.81 41.67 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.799 -171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.757 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.698 ' HG2' HD11 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.02 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp -78.92 132.44 36.74 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -91.11 147.82 22.8 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.94 76.98 0.11 Allowed Glycine 0 CA--C 1.496 -1.112 0 O-C-N 124.461 1.1 . . . . 0.0 113.85 -167.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.422 ' C ' HD21 ' A' ' 89' ' ' ASN . 1.2 t70 -162.02 -74.68 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.594 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -146.53 -42.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -166.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.814 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.02 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.753 HG23 ' HB ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.757 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.815 HG21 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' H ' HG13 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.815 ' HG3' HG21 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.753 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.743 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.761 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.694 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 1.05 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.751 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.623 ' HB ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.865 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.66 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.865 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.751 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 1.05 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.698 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.56 89.72 3.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.625 0.726 . . . . 0.0 110.013 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -77.29 -56.8 4.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.496 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.814 ' HB2' HG11 ' A' ' 42' ' ' VAL . 89.1 p 53.03 107.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.011 0.925 . . . . 0.0 112.649 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.559 ' HB2' HD12 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.734 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.646 ' HD1' HD13 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.812 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.812 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 24' ' ' LEU . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD11 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.598 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.804 ' HG2' HG21 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.675 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.849 HD13 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.849 HG13 HD13 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.662 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.532 HG22 HG21 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.675 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.596 ' CD2' ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.73 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 37.9 tt0 -99.65 126.9 45.75 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -90.72 174.93 7.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.545 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -72.6 -2.31 19.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.405 0.622 . . . . 0.0 109.755 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 p -94.47 -17.05 22.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.637 0.732 . . . . 0.0 109.217 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -20.89 42.25 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.908 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.67 118.16 16.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.443 1.116 . . . . 0.0 110.815 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm -110.03 122.25 47.16 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.824 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.73 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.678 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.51 ' HG2' HD11 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.072 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm -79.81 108.21 13.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 22.4 tt0 -125.16 144.13 50.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.313 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.2 2.98 54.37 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -166.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 t70 79.24 -35.2 0.16 Allowed 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 113.518 -1.341 . . . . 0.0 112.702 167.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.097 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 -104.7 -30.92 9.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.721 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.072 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.678 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.554 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.618 HD11 ' HE3' ' A' ' 113' ' ' MET . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.709 ' HA ' HG23 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.721 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.097 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.551 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.898 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 1.125 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.618 ' HE3' HD11 ' A' ' 98' ' ' ILE . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.646 HD13 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.461 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 1.125 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.898 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HB3' ' HE1' ' A' ' 43' ' ' HIS . 67.5 mtt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.801 0.334 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.55 89.68 6.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.15 0.5 . . . . 0.0 110.901 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.11 38.73 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m -67.1 137.01 56.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.711 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.607 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.871 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB2' HG21 ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 34.7 m-20 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.589 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.696 ' HD1' HD13 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.85 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.85 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 ' HG3' ' A' ' 20' ' ' LYS . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.867 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.867 HD11 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.711 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.583 ' HE1' ' HB3' ' A' ' 1' ' ' MET . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 64' ' ' THR . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' HE2' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.698 HG21 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.698 HG22 HG21 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.761 HD12 ' HB3' ' A' ' 74' ' ' MET . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.817 HG21 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.735 HD13 ' HE1' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.666 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.907 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -119.86 135.35 54.91 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.5 p -98.62 -175.1 2.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 111.991 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.761 ' HB3' HD12 ' A' ' 59' ' ' ILE . 4.2 ppp? -76.82 -2.11 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.27 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 p -92.93 -21.79 19.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.91 -18.78 36.5 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.488 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.89 125.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.687 0.756 . . . . 0.0 111.581 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.907 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? -110.95 141.26 44.63 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.848 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.713 HG13 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 94' ' ' THR . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.813 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm -78.86 135.31 36.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -100.18 141.75 32.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.06 76.74 0.72 Allowed Glycine 0 CA--C 1.496 -1.147 0 CA-C-O 122.138 0.854 . . . . 0.0 114.11 -166.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.0 -76.22 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.437 -1.381 . . . . 0.0 109.525 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.758 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -147.69 -36.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -166.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 103' ' ' GLU . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.813 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.76 HG23 ' HB ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.871 HG21 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.67 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.713 ' H ' HG13 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.829 HD11 ' HE1' ' A' ' 113' ' ' MET . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.871 ' HG3' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.412 ' O ' HG11 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.913 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.894 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 105' ' ' ASN . 0.2 OUTLIER -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.62 ' HB ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.829 ' HE1' HD11 ' A' ' 98' ' ' ILE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.696 HD13 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.732 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.732 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.871 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.591 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.581 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' HB2' ' HE1' ' A' ' 3' ' ' PHE . 9.3 ptp . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.578 0.704 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -106.0 127.57 53.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.557 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 91.5 m-85 -120.88 -63.87 1.3 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.706 ' HB2' HG11 ' A' ' 42' ' ' VAL . 27.2 p 62.16 121.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.071 0.949 . . . . 0.0 112.549 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.62 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.523 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.8 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.622 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.707 ' HD2' ' HH ' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HD1' HD13 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.776 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.776 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.811 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.702 HG23 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' HG2' HG21 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.728 ' HB3' HD13 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.728 HD13 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.509 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 40.3 t-80 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.677 HG21 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.665 HD11 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.896 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -115.45 114.94 25.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.8 p -146.52 -2.11 0.68 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.717 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttm -75.19 -3.76 34.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 p 74.54 27.96 1.31 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.905 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.83 -63.5 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.09 -2.323 . . . . 0.0 112.564 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.81 113.44 13.28 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.798 0.809 . . . . 0.0 111.806 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.896 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -96.93 144.33 26.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.633 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.692 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.786 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.665 ' HG2' HD11 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt -80.31 135.5 36.22 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -96.44 144.82 26.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.97 79.87 0.13 Allowed Glycine 0 CA--C 1.502 -0.771 0 O-C-N 123.912 0.758 . . . . 0.0 114.523 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.03 -69.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.726 -1.237 . . . . 0.0 109.214 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 1.06 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 -147.74 -41.98 0.17 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.932 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.03 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.886 HG23 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.786 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.683 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.683 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 1.048 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.886 ' HB ' HG23 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.923 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.932 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.477 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.8 OUTLIER -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG ' ' A' ' 7' ' ' TYR . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.579 ' HB ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 1.048 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.662 HD13 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.707 ' HH ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.62 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.619 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.5 pp0? -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.805 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.432 ' HG2' ' NE2' ' A' ' 8' ' ' GLN . 12.3 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.701 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.913 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.861 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.861 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.972 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HG2' HG23 ' A' ' 64' ' ' THR . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' HIS . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.972 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.738 HG23 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.566 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG22 HG23 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.693 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.63 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HD2' ' HB2' ' A' ' 104' ' ' PHE . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 1.0 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.776 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.754 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.054 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.876 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 1.0 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.701 HD12 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.727 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.566 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.805 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.534 ' CG ' HD11 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB3' HD13 ' A' ' 127' ' ' ILE . 18.0 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 125' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' LYS . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.815 ' HD1' HD12 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.912 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 50' ' ' LEU . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.901 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.017 ' HG2' HG23 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.71 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.901 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HD23 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 1.017 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.671 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.512 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.781 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.743 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.103 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.03 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.743 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.755 ' HG3' HG11 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 98' ' ' ILE . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' HG23 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.724 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.103 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.03 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.94 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.796 HG23 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.815 HD12 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.796 ' HE3' HG23 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.908 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.94 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.99 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.103 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.586 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.932 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' N ' HD11 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' HD12 ' A' ' 24' ' ' LEU . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.848 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.614 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.669 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 82' ' ' VAL . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt . . . . . 0 N--CA 1.432 -1.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 68' ' ' GLU . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.023 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.812 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.812 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.023 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.718 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.019 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 6.3 t30 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.518 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.938 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.938 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 1.019 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 4.4 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.111 0.482 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.466 ' OE1' HG22 ' A' ' 38' ' ' VAL . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.865 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.829 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD1' HD12 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.782 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.782 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.829 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' HA2' ' A' ' 55' ' ' GLY . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' OE1' ' A' ' 8' ' ' GLN . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.802 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.802 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.667 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.433 -1.292 0 CA-C-O 121.366 0.603 . . . . 0.0 111.704 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.689 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.099 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.78 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.811 HG22 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.811 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.78 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.099 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.53 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 1.142 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 6.1 t30 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.924 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.742 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.924 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.697 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.48 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.865 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.525 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 1.142 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.433 0.635 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 5.1 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.955 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.861 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.773 ' HD1' HD12 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.819 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.819 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HG2' HD12 ' A' ' 28' ' ' LEU . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 88.1 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.679 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.679 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.955 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.869 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 1.028 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.869 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 58' ' ' VAL . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.028 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.651 ' HB ' HG23 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' H ' HG11 ' A' ' 79' ' ' VAL . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.688 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.773 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.644 ' HB3' HG11 ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.878 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 122.241 1.02 . . . . 0.0 113.073 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.696 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 14.0 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.941 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD1' HD12 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.797 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.797 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.582 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.576 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.753 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.485 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' H ' ' HB ' ' A' ' 53' ' ' THR . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.722 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.75 ' HG2' HG23 ' A' ' 64' ' ' THR . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.79 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.79 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.851 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' CE ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 84' ' ' LYS . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.748 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.748 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 120.982 0.42 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.755 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.026 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.997 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.755 ' HB ' HG23 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.761 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.633 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.026 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.997 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.499 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 10.5 t30 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.937 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.937 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.69 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.487 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.875 ' HB2' HG13 ' A' ' 42' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.879 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' HD13 ' A' ' 118' ' ' ILE . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.879 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.892 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.793 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB2' HG22 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.684 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.722 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.639 HG23 HG22 ' A' ' 58' ' ' VAL . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.684 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.848 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 121.0 0.429 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG11 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' HD13 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.845 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.774 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.67 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' H ' HG11 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.762 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.808 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.727 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.08 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.911 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.748 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.921 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 1.08 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.727 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.802 ' HB2' HG13 ' A' ' 42' ' ' VAL . 89.1 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.967 0.889 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 125' ' ' LYS . 80.3 mm-40 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.594 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.847 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.713 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.816 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.816 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 29' ' ' ILE . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.682 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.611 HE21 HG22 ' A' ' 29' ' ' ILE . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 8' ' ' GLN . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.802 HG13 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.512 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.844 ' HG2' HG23 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.833 HG13 HD12 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.671 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG22 HG23 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.844 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.783 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.753 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.085 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.741 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.875 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.741 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.085 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.614 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.919 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.433 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.158 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.62 ' O ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.713 HD12 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.847 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 1.158 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.919 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.91 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 7.8 m120 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.866 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HD1' HD12 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.854 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.878 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.878 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG2' HG23 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.768 HG23 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.768 HG22 HG23 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 59' ' ' ILE . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.891 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.565 HD11 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.689 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.922 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.355 0.598 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.817 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.781 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.754 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.93 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.817 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' H ' HG11 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.911 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.93 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.846 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.47 ' HE1' ' CZ ' ' A' ' 18' ' ' PHE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.832 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.746 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.746 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.598 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.696 ' HB2' HG13 ' A' ' 42' ' ' VAL . 27.2 p . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.848 0.833 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB3' HD13 ' A' ' 127' ' ' ILE . 17.6 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' CG ' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.85 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.792 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.501 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.792 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 28' ' ' LEU . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.689 HG21 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.777 ' HG2' HG23 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.716 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.685 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.424 HG22 HD22 ' A' ' 61' ' ' ASN . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.424 HD22 HG22 ' A' ' 59' ' ' ILE . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.716 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.777 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.594 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.91 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.118 0.485 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.677 ' HG2' HD13 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.937 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.794 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.701 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 1.076 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.921 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.937 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 1.076 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.576 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.441 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.263 0.554 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -104.57 96.44 6.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.763 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.519 ' HE2' ' HG3' ' A' ' 126' ' ' ARG . 18.0 t80 -137.63 39.95 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.563 . . . . 0.0 109.789 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m -48.85 137.06 13.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.619 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' HD13 ' A' ' 127' ' ' ILE . 2.5 pp0? -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.805 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.432 ' HG2' ' NE2' ' A' ' 8' ' ' GLN . 12.3 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.701 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.913 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.861 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.861 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.972 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HG2' HG23 ' A' ' 64' ' ' THR . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' HIS . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.972 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.738 HG23 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.566 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG22 HG23 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.693 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -102.57 119.59 39.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.0 p -89.73 172.66 8.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.135 0.493 . . . . 0.0 111.535 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ptm -68.98 -2.69 10.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.965 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.4 p -97.34 -17.93 19.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.583 0.706 . . . . 0.0 109.161 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.92 57.93 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.806 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -75.82 114.1 14.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.122 0.963 . . . . 0.0 110.833 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp -110.19 127.21 54.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.72 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.63 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -80.59 109.47 15.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 28.6 tt0 -124.4 142.48 51.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.558 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.91 55.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -165.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.4 -30.61 0.17 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 113.6 -1.3 . . . . 0.0 112.745 167.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 -99.78 -34.99 9.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HD2' ' HB2' ' A' ' 104' ' ' PHE . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 1.0 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.776 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.754 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.054 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.876 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 1.0 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.701 HD12 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.727 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.566 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.805 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.519 ' HG3' ' HE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.289 0.566 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -105.32 115.79 30.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.113 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -136.14 39.47 2.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t -39.85 138.36 0.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.534 ' CG ' HD11 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB3' HD13 ' A' ' 127' ' ' ILE . 18.0 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 125' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' LYS . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.815 ' HD1' HD12 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.912 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 50' ' ' LEU . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.901 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.017 ' HG2' HG23 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.71 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.901 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HD23 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 1.017 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.671 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.512 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.781 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 -103.2 137.74 40.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.52 HG23 ' HE3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -107.39 177.5 4.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 172.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.3 tpp -72.5 -0.74 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.878 0.847 . . . . 0.0 110.045 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.4 p -88.82 -3.31 58.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.77 -11.82 38.65 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.276 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.57 118.77 23.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.001 0.905 . . . . 0.0 110.266 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? -106.18 124.34 49.44 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.333 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.743 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt -79.29 136.12 36.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.57 145.17 24.65 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.01 7.45 1.18 Allowed Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -159.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -84.6 -67.12 0.82 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.84 0.32 . . . . 0.0 110.813 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.103 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 -150.12 -40.85 0.13 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.03 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.743 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.755 ' HG3' HG11 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 98' ' ' ILE . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' HG23 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.724 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.103 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.03 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.94 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.796 HG23 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.815 HD12 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.796 ' HE3' HG23 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.908 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.94 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.877 0.37 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.48 113.35 23.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -134.15 -45.37 0.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.142 -0.349 . . . . 0.0 110.846 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.99 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p 58.66 112.49 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 174.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.103 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.586 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.932 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' N ' HD11 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' HD12 ' A' ' 24' ' ' LEU . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.848 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.614 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.669 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 82' ' ' VAL . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 -95.89 122.71 38.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -86.28 174.82 8.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.97 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 ptp -70.42 -2.0 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 p -97.08 -9.03 28.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.2 70.54 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.025 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -81.58 127.55 32.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.41 0.624 . . . . 0.0 110.437 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt -110.01 134.27 52.31 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.304 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 68' ' ' GLU . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp -79.99 132.65 36.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -93.33 144.85 24.93 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.54 82.73 0.08 OUTLIER Glycine 0 CA--C 1.498 -1.012 0 O-C-N 123.982 0.801 . . . . 0.0 114.356 -165.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -159.07 -73.01 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.105 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.023 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 -149.95 -36.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -171.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.812 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.812 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.023 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.718 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.019 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 6.3 t30 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.518 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.938 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.938 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 1.019 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -104.17 95.04 5.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.43 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -101.54 45.56 0.96 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.694 0.759 . . . . 0.0 110.186 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 4.4 m -62.12 144.67 55.02 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.166 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' OE1' HG22 ' A' ' 38' ' ' VAL . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.865 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.829 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD1' HD12 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.782 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.782 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.829 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' HA2' ' A' ' 55' ' ' GLY . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' OE1' ' A' ' 8' ' ' GLN . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.802 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.802 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.667 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.56 131.88 52.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 p -94.58 179.01 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.429 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 tpp -78.94 -1.88 37.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.448 0.642 . . . . 0.0 110.203 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 p -94.75 -6.05 43.95 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.54 -28.8 7.86 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.553 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -72.57 116.16 12.7 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.706 0.765 . . . . 0.0 110.98 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -101.29 142.91 32.02 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.704 177.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.689 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp -79.77 135.28 36.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 88' ' ' ASP . 28.2 tt0 -91.8 145.76 24.3 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.6 78.94 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.782 0 CA-C-O 122.071 0.817 . . . . 0.0 113.926 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 86' ' ' GLU . 7.7 t0 -158.7 -74.07 0.08 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.113 -1.543 . . . . 0.0 108.817 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.099 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 -154.32 -35.87 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -171.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.78 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.811 HG22 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.811 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.78 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.099 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.53 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 1.142 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 6.1 t30 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.924 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.742 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.924 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.697 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.48 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.865 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.525 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 1.142 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.371 0.605 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.26 110.69 22.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.888 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -101.51 44.73 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.188 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m -69.7 126.05 28.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.582 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 5.1 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.955 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.861 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.773 ' HD1' HD12 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.819 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.819 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HG2' HD12 ' A' ' 28' ' ' LEU . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 88.1 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.679 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.679 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.955 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.869 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 1.028 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.869 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 58' ' ' VAL . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 74' ' ' MET . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.028 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 -110.74 128.22 55.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.6 p -89.27 166.23 13.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 59' ' ' ILE . 21.8 ptm -65.07 -1.85 2.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.358 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.9 p -95.77 -22.13 17.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.7 -17.7 13.39 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.043 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 8.0 mp0 -79.35 121.05 24.65 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.128 0.966 . . . . 0.0 112.104 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt -112.22 135.36 52.99 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.111 -1.858 . . . . 0.0 110.582 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -83.0 133.61 35.09 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 88' ' ' ASP . 27.4 tt0 -93.94 145.47 24.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.42 78.36 0.06 OUTLIER Glycine 0 CA--C 1.502 -0.747 0 O-C-N 124.088 0.868 . . . . 0.0 114.046 -169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 86' ' ' GLU . 6.2 t70 -159.4 -72.19 0.08 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.332 -1.434 . . . . 0.0 109.213 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 -153.41 -35.7 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -171.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.651 ' HB ' HG23 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' H ' HG11 ' A' ' 79' ' ' VAL . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.688 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.773 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.644 ' HB3' HG11 ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.878 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -104.61 94.64 5.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.095 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.01 -66.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p 54.41 108.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.073 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.696 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 14.0 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.941 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD1' HD12 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.797 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.797 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.582 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.576 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.753 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.485 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' H ' ' HB ' ' A' ' 53' ' ' THR . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.722 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.75 ' HG2' HG23 ' A' ' 64' ' ' THR . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.79 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 74' ' ' MET . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 74' ' ' MET . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.79 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.851 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' CE ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 84' ' ' LYS . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.748 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 -101.43 129.81 47.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -90.5 -173.75 3.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.072 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.578 ' HG3' ' HG2' ' A' ' 57' ' ' LYS . 50.3 ttm -73.02 -7.59 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.152 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.2 p -95.06 -11.63 27.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.317 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.08 -20.14 50.68 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.138 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.55 126.5 30.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 110.41 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.748 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt -109.4 139.02 44.89 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.249 -175.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.755 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -82.43 107.0 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.603 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 25.9 tt0 -126.88 143.57 51.23 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.313 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.51 0.3 40.19 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -168.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 78.82 -39.12 0.23 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 113.398 -1.401 . . . . 0.0 112.429 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.026 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 -100.4 -30.27 11.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.564 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.997 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.755 ' HB ' HG23 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.761 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.633 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.026 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.997 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.499 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 10.5 t30 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.937 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.937 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.69 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.487 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.03 0.443 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -78.97 89.6 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -71.46 74.87 0.77 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.155 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.875 ' HB2' HG13 ' A' ' 42' ' ' VAL . 2.1 t -107.92 142.01 38.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 172.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.879 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' HD13 ' A' ' 118' ' ' ILE . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.879 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.892 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.793 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB2' HG22 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.684 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.722 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.639 HG23 HG22 ' A' ' 58' ' ' VAL . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.684 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 -113.44 118.54 34.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 p -89.62 -177.96 5.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 112.137 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.4 ttm -72.0 -3.6 23.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.413 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.7 p -96.44 -6.95 36.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.714 0.768 . . . . 0.0 109.481 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.97 -27.26 5.56 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.468 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.94 114.15 17.64 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.848 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt -109.64 141.81 41.67 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.799 -171.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG11 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' HD13 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp -78.92 132.44 36.74 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -91.11 147.82 22.8 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.94 76.98 0.11 Allowed Glycine 0 CA--C 1.496 -1.112 0 O-C-N 124.461 1.1 . . . . 0.0 113.85 -167.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' C ' HD22 ' A' ' 89' ' ' ASN . 1.2 t70 -162.02 -74.68 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.594 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -146.53 -42.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -166.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.845 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.774 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.67 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' H ' HG11 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.762 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.808 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.727 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.08 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.911 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.748 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.921 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 1.08 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.727 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.56 89.72 3.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.625 0.726 . . . . 0.0 110.013 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -77.29 -56.8 4.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.496 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.802 ' HB2' HG13 ' A' ' 42' ' ' VAL . 89.1 p 53.03 107.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.011 0.925 . . . . 0.0 112.649 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 125' ' ' LYS . 80.3 mm-40 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.594 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.847 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.713 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.816 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.816 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 29' ' ' ILE . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.682 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.611 HE21 HG22 ' A' ' 29' ' ' ILE . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 8' ' ' GLN . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.802 HG13 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.512 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.844 ' HG2' HG23 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.833 HG13 HD12 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.671 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG22 HG23 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.844 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.783 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -99.65 126.9 45.75 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -90.72 174.93 7.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.545 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -72.6 -2.31 19.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.405 0.622 . . . . 0.0 109.755 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 p -94.47 -17.05 22.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.637 0.732 . . . . 0.0 109.217 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -20.89 42.25 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.908 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.67 118.16 16.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.443 1.116 . . . . 0.0 110.815 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm -110.03 122.25 47.16 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.824 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.753 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm -79.81 108.21 13.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 22.4 tt0 -125.16 144.13 50.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.313 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.2 2.98 54.37 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -166.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 t70 79.24 -35.2 0.16 Allowed 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 113.518 -1.341 . . . . 0.0 112.702 167.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.085 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 -104.7 -30.92 9.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.741 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.875 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.741 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.085 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.614 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.919 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.433 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.158 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.62 ' O ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.713 HD12 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.847 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 1.158 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.919 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' HB3' ' HE1' ' A' ' 43' ' ' HIS . 67.5 mtt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.801 0.334 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.55 89.68 6.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.15 0.5 . . . . 0.0 110.901 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.11 38.73 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m -67.1 137.01 56.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.91 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 7.8 m120 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.866 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HD1' HD12 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.854 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.878 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.878 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HE1' ' HB3' ' A' ' 1' ' ' MET . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG2' HG23 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.768 HG23 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.768 HG22 HG23 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 74' ' ' MET . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.891 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.565 HD11 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.689 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -119.86 135.35 54.91 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.655 HG21 ' HD3' ' A' ' 96' ' ' LYS . 73.5 p -98.62 -175.1 2.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 111.991 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.779 ' HB3' HD11 ' A' ' 59' ' ' ILE . 4.2 ppp? -76.82 -2.11 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.27 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 p -92.93 -21.79 19.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.91 -18.78 36.5 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.488 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.89 125.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.687 0.756 . . . . 0.0 111.581 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.922 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? -110.95 141.26 44.63 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.848 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.817 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.781 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm -78.86 135.31 36.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -100.18 141.75 32.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.06 76.74 0.72 Allowed Glycine 0 CA--C 1.496 -1.147 0 CA-C-O 122.138 0.854 . . . . 0.0 114.11 -166.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.0 -76.22 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.437 -1.381 . . . . 0.0 109.525 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.754 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -147.69 -36.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -166.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.93 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.817 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' H ' HG11 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.911 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.93 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.846 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.47 ' HE1' ' CZ ' ' A' ' 18' ' ' PHE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.832 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.746 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.746 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.598 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB2' ' HE1' ' A' ' 3' ' ' PHE . 9.3 ptp . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.578 0.704 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -106.0 127.57 53.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 91.5 m-85 -120.88 -63.87 1.3 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.696 ' HB2' HG13 ' A' ' 42' ' ' VAL . 27.2 p 62.16 121.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.071 0.949 . . . . 0.0 112.549 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB3' HD13 ' A' ' 127' ' ' ILE . 17.6 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' CG ' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.85 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.792 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.501 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.792 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 28' ' ' LEU . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.689 HG21 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.777 ' HG2' HG23 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.716 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.685 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.424 HG22 HD22 ' A' ' 61' ' ' ASN . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.424 HD22 HG22 ' A' ' 59' ' ' ILE . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.716 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.777 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.594 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.91 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -115.45 114.94 25.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.8 p -146.52 -2.11 0.68 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.717 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttm -75.19 -3.76 34.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 p 74.54 27.96 1.31 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.905 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.83 -63.5 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.09 -2.323 . . . . 0.0 112.564 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.81 113.44 13.28 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.798 0.809 . . . . 0.0 111.806 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -96.93 144.33 26.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.633 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.677 ' HG2' HD13 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt -80.31 135.5 36.22 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -96.44 144.82 26.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.97 79.87 0.13 Allowed Glycine 0 CA--C 1.502 -0.771 0 O-C-N 123.912 0.758 . . . . 0.0 114.523 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.03 -69.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.726 -1.237 . . . . 0.0 109.214 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 -147.74 -41.98 0.17 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.937 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.794 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.701 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 1.076 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.921 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.937 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 1.076 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.576 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.441 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.274 0.559 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.619 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.805 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.41 ' NE2' ' HE3' ' A' ' 125' ' ' LYS . 34.4 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.701 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.913 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.861 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.861 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.972 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HG2' HG23 ' A' ' 64' ' ' THR . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' HIS . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.972 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.738 HG23 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.566 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.738 HG22 HG23 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.468 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 27.6 t-80 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.693 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.63 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HD2' ' HB2' ' A' ' 104' ' ' PHE . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 1.0 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.776 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.754 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.054 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.876 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 1.0 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.701 HD12 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.727 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.566 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.805 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HE3' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.534 ' CG ' HD11 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB3' HD13 ' A' ' 127' ' ' ILE . 1.8 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 125' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 HE21 HG11 ' A' ' 9' ' ' VAL . 80.2 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' LYS . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.815 ' HD1' HD12 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.912 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 50' ' ' LEU . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.901 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.017 ' HG2' HG23 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.71 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.901 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HD23 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 1.017 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.671 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.512 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.781 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.743 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.103 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.03 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.743 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.755 ' HG3' HG11 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' HG23 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.724 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.103 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.03 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.94 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.796 HG23 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.815 HD12 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.796 ' HE3' HG23 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.908 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.94 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.99 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.103 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.586 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.932 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' N ' HD11 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' HD12 ' A' ' 24' ' ' LEU . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.848 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.614 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.669 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 82' ' ' VAL . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt . . . . . 0 N--CA 1.432 -1.327 0 CA-C-O 120.764 0.316 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 68' ' ' GLU . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.023 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.812 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.812 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.023 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.718 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.019 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.2 t-20 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.518 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.938 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.938 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 1.019 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 4.4 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.111 0.482 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.466 ' OE1' HG22 ' A' ' 38' ' ' VAL . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.865 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.829 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD1' HD12 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.782 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.782 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.829 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' HA2' ' A' ' 55' ' ' GLY . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' OE1' ' A' ' 8' ' ' GLN . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.802 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.802 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.667 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.419 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 42.4 t-80 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.433 -1.292 0 CA-C-O 121.366 0.603 . . . . 0.0 111.704 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.689 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.099 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.78 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.811 HG22 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.811 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.78 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.099 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.53 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 1.142 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.4 t-20 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.924 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.742 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.924 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.697 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.48 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.865 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.525 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 1.142 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.433 0.635 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.2 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.955 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.861 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.773 ' HD1' HD12 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.819 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.819 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HG2' HD12 ' A' ' 28' ' ' LEU . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 26.8 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.679 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.679 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.955 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.869 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 1.028 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.869 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 58' ' ' VAL . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.028 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.651 ' HB ' HG23 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' H ' HG11 ' A' ' 79' ' ' VAL . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.688 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.773 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.644 ' HB3' HG11 ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.878 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 122.241 1.02 . . . . 0.0 113.073 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.696 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.3 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.941 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD1' HD12 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.797 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.797 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.582 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.576 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.753 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.485 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' H ' ' HB ' ' A' ' 53' ' ' THR . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.722 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.75 ' HG2' HG23 ' A' ' 64' ' ' THR . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.79 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.79 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.851 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' CE ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 84' ' ' LYS . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.748 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.748 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 120.982 0.42 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.755 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.026 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.997 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.755 ' HB ' HG23 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.761 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.633 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.026 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.997 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.499 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 21.4 t-20 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.937 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.937 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.69 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.487 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.875 ' HB2' HG13 ' A' ' 42' ' ' VAL . 2.1 t . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.879 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' HD13 ' A' ' 118' ' ' ILE . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.879 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.892 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.793 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB2' HG22 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.684 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.722 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.639 HG23 HG22 ' A' ' 58' ' ' VAL . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.684 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.848 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 121.0 0.429 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG11 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' HD13 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp . . . . . 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.845 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.774 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.67 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' H ' HG11 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.762 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.808 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.727 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.08 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.911 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.748 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.921 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 1.08 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.727 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.802 ' HB2' HG13 ' A' ' 42' ' ' VAL . 89.1 p . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.967 0.889 . . . . 0.0 112.649 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 125' ' ' LYS . 14.6 mm100 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.594 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.847 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.713 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.816 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.816 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 29' ' ' ILE . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.682 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.611 HE21 HG22 ' A' ' 29' ' ' ILE . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 8' ' ' GLN . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.802 HG13 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.512 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.844 ' HG2' HG23 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.833 HG13 HD12 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.671 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG22 HG23 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.844 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.783 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm . . . . . 0 N--CA 1.434 -1.257 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.753 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.085 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.741 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.875 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.741 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.085 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.614 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.919 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.433 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.158 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.62 ' O ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.713 HD12 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.847 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 1.158 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.919 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.91 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.448 HD22 HG13 ' A' ' 119' ' ' VAL . 34.7 m-20 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.866 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HD1' HD12 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.854 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.878 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.878 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG2' HG23 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.768 HG23 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.768 HG22 HG23 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 59' ' ' ILE . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.891 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.565 HD11 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.689 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.922 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.355 0.598 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.817 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.781 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.754 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.93 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.817 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' H ' HG11 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.911 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.93 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.479 ' C ' HD22 ' A' ' 105' ' ' ASN . 0.2 OUTLIER -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.846 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.47 ' HE1' ' CZ ' ' A' ' 18' ' ' PHE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.832 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 14' ' ' ASN . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.746 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.746 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.598 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.696 ' HB2' HG13 ' A' ' 42' ' ' VAL . 27.2 p . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 121.848 0.833 . . . . 0.0 112.549 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB3' HD13 ' A' ' 127' ' ' ILE . 1.8 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' CG ' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.85 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.792 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.501 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.792 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 28' ' ' LEU . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.689 HG21 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.777 ' HG2' HG23 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.716 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.685 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.424 HG22 HD22 ' A' ' 61' ' ' ASN . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.509 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 40.3 t-80 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.424 HD22 HG22 ' A' ' 59' ' ' ILE . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.716 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.777 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.594 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.91 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.118 0.485 . . . . 0.0 111.633 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.677 ' HG2' HD13 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.937 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.794 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.701 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 1.076 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.921 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.937 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.8 OUTLIER -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 1.076 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.576 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.441 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.263 0.554 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -104.57 96.44 6.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.763 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.519 ' HE2' ' HG3' ' A' ' 126' ' ' ARG . 18.0 t80 -137.63 39.95 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.283 0.563 . . . . 0.0 109.789 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 6.3 m -48.85 137.06 13.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.32 -168.69 41.07 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.619 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.7 tptt -97.57 146.51 25.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 117.445 0.622 . . . . 0.0 110.319 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CD2' HD11 ' A' ' 109' ' ' ILE . 40.0 m-85 -134.68 118.1 16.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -97.65 126.0 42.72 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.479 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.805 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.5 t -63.85 132.89 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.547 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.41 ' NE2' ' HE3' ' A' ' 125' ' ' LYS . 34.4 mt-30 -108.87 -68.17 0.93 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.3 m -97.37 152.02 19.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG2' ' CB ' ' A' ' 122' ' ' ARG . 13.8 mt-30 -152.81 156.05 38.31 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.4 pt-20 -129.11 155.43 45.48 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.45 0.643 . . . . 0.0 112.144 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 59.54 39.26 21.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.345 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -72.23 -43.89 63.73 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.766 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.5 mt-10 -58.95 -60.19 11.35 Favored Pre-proline 0 C--O 1.206 -1.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.522 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 17.9 Cg_endo -58.07 -28.26 82.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.739 1.626 . . . . 0.0 111.994 -172.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.701 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.0 t80 -72.17 -51.77 19.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.087 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.913 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 5.9 mmt -69.18 -31.89 70.83 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.02 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 29' ' ' ILE . 22.4 mttt -59.29 -48.11 82.84 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.27 -19.19 61.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.645 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.913 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 49.9 mmm -78.95 -6.78 57.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.51 28.62 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.087 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -91.57 128.71 45.45 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-O 121.618 0.723 . . . . 0.0 110.489 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -70.23 152.09 66.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 0.0 111.155 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.79 -35.74 45.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.553 0.533 . . . . 0.0 111.525 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.03 -46.06 82.86 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.507 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 48.7 mt -74.22 -32.51 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.358 0.599 . . . . 0.0 110.048 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.48 -46.89 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.968 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -63.42 -29.4 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.818 0.342 . . . . 0.0 111.415 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -79.2 -43.66 23.41 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.448 0.642 . . . . 0.0 109.859 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.861 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -80.74 -9.74 85.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.42 -16.1 32.69 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -168.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.51 16.03 8.88 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.936 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.861 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -83.63 137.97 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.605 0.717 . . . . 0.0 111.502 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.78 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.2 mptt -127.88 -108.85 0.29 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.327 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.26 179.5 25.18 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.83 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 125.06 58.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.7 p -112.06 149.22 32.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.49 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 31.1 tt0 -127.96 130.39 48.33 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 4' ' ' SER . 18.2 mm -122.45 116.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.212 0.32 . . . . 0.0 110.45 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.972 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 23.4 t -124.55 112.15 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 2.8 t-80 -102.32 116.37 32.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.344 0.592 . . . . 0.0 110.947 -175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -119.89 103.86 9.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.725 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.44 -104.18 1.32 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.031 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.0 mptm? -96.95 -43.15 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.013 0.911 . . . . 0.0 110.018 172.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HG2' HG23 ' A' ' 64' ' ' THR . 23.0 mttt -73.35 134.89 44.24 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.051 -172.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 43' ' ' HIS . 59.3 t -122.09 132.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.039 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.972 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 51.5 mttm -88.75 129.01 35.64 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.313 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -123.27 114.66 20.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.364 0.602 . . . . 0.0 110.573 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.9 m -112.97 115.94 29.19 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.9 mp -128.32 127.27 67.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.036 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.738 HG23 HG22 ' A' ' 58' ' ' VAL . 8.1 m -96.28 125.07 40.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.323 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.566 ' HE1' ' NH1' ' A' ' 122' ' ' ARG . 81.1 m-85 -110.4 97.57 7.0 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 -94.27 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.315 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.6 p -98.25 -37.01 9.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -91.76 146.12 24.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.893 0.378 . . . . 0.0 110.813 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.738 HG22 HG23 ' A' ' 53' ' ' THR . 5.0 t -122.27 126.67 74.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.417 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -106.75 126.32 62.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.823 0.344 . . . . 0.0 110.288 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.468 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 27.6 t-80 -114.16 118.4 33.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -144.19 142.2 30.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 0.0 110.184 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 37.4 mt-10 -122.96 142.63 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.4 p90 -140.49 152.78 45.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.336 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.786 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.9 m -105.89 132.01 52.51 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.198 0.311 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.693 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -65.86 126.59 28.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 13.35 68.79 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 11.6 tp10 -131.95 142.64 49.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.286 -171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.68 120.79 17.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -134.46 146.1 49.46 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.926 0.869 . . . . 0.0 110.34 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.677 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 24.8 mp0 -92.66 126.28 37.68 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.449 -170.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -95.56 127.1 41.31 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.596 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -102.57 119.59 39.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.504 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.0 p -89.73 172.66 8.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.135 0.493 . . . . 0.0 111.535 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ptm -68.98 -2.69 10.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.965 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.4 p -97.34 -17.93 19.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.583 0.706 . . . . 0.0 109.161 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.92 57.93 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.806 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -75.82 114.1 14.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.122 0.963 . . . . 0.0 110.833 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 17.4 tttp -110.19 127.21 54.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.72 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -130.16 137.72 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.493 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.63 ' CG ' ' HG3' ' A' ' 70' ' ' GLU . 24.9 mtmm -63.76 121.17 13.35 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.163 0.983 . . . . 0.0 111.809 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 95' ' ' PHE . . . -133.9 143.95 48.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.917 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.59 114.9 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 121.923 -0.486 . . . . 0.0 110.51 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 8.7 p -112.79 123.6 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.704 0.764 . . . . 0.0 112.37 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 85' ' ' MET . 2.6 tmmm? -143.12 166.55 24.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 168.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -80.59 109.47 15.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.71 0.767 . . . . 0.0 110.82 -159.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 28.6 tt0 -124.4 142.48 51.27 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.558 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.9 -1.91 55.39 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -165.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.4 -30.61 0.17 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 113.6 -1.3 . . . . 0.0 112.745 167.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 14.6 m120 -99.78 -34.99 9.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HD2' ' HB2' ' A' ' 104' ' ' PHE . 43.2 tttm -146.38 -179.44 6.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.322 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.043 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.0 mpt? -102.64 151.85 21.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.309 0.576 . . . . 0.0 111.98 -162.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 101' ' ' VAL . 67.6 t -108.41 136.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.701 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -129.97 123.29 30.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.146 0.498 . . . . 0.0 110.164 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 123.46 42.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.737 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 53.1 p90 -154.21 144.41 22.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.416 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 28.3 mtpp 55.7 22.77 5.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -173.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.85 -8.47 75.82 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.553 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -95.19 148.23 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 1.0 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -112.06 114.6 27.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.471 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -114.01 116.57 29.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.341 . . . . 0.0 111.204 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.776 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.43 139.63 23.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.169 0.509 . . . . 0.0 110.323 179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.754 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.93 137.69 53.72 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.054 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 2.6 tt0 -127.17 115.4 19.06 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 12.6 t80 -109.03 108.06 18.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.797 0.808 . . . . 0.0 111.056 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -114.14 101.15 8.94 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.878 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.39 -91.93 0.17 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.947 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 126' ' ' ARG . 3.1 p-10 -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.11 147.37 36.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.19 -177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 2.3 mt -126.73 131.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.543 0.211 . . . . 0.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 3.2 m -106.31 110.46 22.7 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -101.61 115.27 30.15 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 101' ' ' VAL . 8.8 m -112.98 117.94 33.46 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.876 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.7 ttt -102.5 138.57 39.25 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 1.0 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.3 m -127.58 113.81 16.59 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.093 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -114.02 106.99 15.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.78 -96.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.125 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -97.81 -30.37 12.82 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.866 -0.197 . . . . 0.0 111.221 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.701 HD12 ' HD1' ' A' ' 18' ' ' PHE . 6.3 pt -79.07 123.67 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.123 0.487 . . . . 0.0 111.501 -175.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.96 142.42 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 37.1 t80 -132.94 139.18 47.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.727 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -134.25 148.0 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.154 -1.018 . . . . 0.0 111.496 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.566 ' NH1' ' HE1' ' A' ' 54' ' ' TYR . 20.6 mtm-85 -137.48 145.03 42.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.087 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 93.6 t -117.23 115.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.805 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 5.9 m -102.21 134.07 46.06 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HE3' ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -120.92 144.06 48.63 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.519 ' HG3' ' HE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -54.88 134.32 48.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.983 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.389 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.289 0.566 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -105.32 115.79 30.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.113 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -136.14 39.47 2.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 12.1 t -39.85 138.36 0.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.232 1.015 . . . . 0.0 113.452 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 -171.44 38.0 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.03 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' CG ' HD11 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -98.82 139.19 34.87 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.601 0.7 . . . . 0.0 109.269 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.534 ' CG ' HD11 ' A' ' 109' ' ' ILE . 18.2 m-85 -128.17 120.66 27.75 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB3' HD13 ' A' ' 127' ' ' ILE . 1.8 pt20 -92.77 131.99 37.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 16.8 t -65.58 147.41 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 125' ' ' LYS . 13.4 mm-40 -129.54 -61.77 1.0 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.737 0.779 . . . . 0.0 110.939 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 0.4 OUTLIER -98.55 142.2 30.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.257 177.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 HE21 HG11 ' A' ' 9' ' ' VAL . 80.2 mt-30 -146.43 158.88 43.95 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 121' ' ' LYS . 6.6 mm-40 -130.71 147.45 52.38 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.159 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 3.0 m-20 53.1 44.26 30.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.502 173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 31.4 t80 -72.55 -36.8 68.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.654 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -60.0 -56.93 30.61 Favored Pre-proline 0 C--O 1.205 -1.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.004 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 10.0 Cg_endo -55.45 -37.5 94.8 Favored 'Trans proline' 0 CA--C 1.511 -0.629 0 C-N-CA 122.214 1.942 . . . . 0.0 111.659 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.815 ' HD1' HD12 ' A' ' 118' ' ' ILE . 17.0 t80 -67.12 -51.88 48.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.98 -31.61 69.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.5 0.19 . . . . 0.0 111.366 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.596 ' HG3' HG13 ' A' ' 29' ' ' ILE . 13.5 mttm -60.82 -46.8 89.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.17 -21.33 63.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.811 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 9.9 mmt -80.98 -2.19 46.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.208 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.53 42.69 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.382 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 12.7 tp -90.61 129.62 44.19 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-O 121.472 0.653 . . . . 0.0 111.129 -173.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.912 ' HG2' HD13 ' A' ' 28' ' ' LEU . 5.7 Cg_endo -68.66 150.23 74.34 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.607 2.871 . . . . 0.0 111.634 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -51.31 -39.81 57.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 15.0 t70 -63.8 -48.31 77.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 25' ' ' PRO . 10.1 mp -70.49 -31.49 68.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.831 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 16' ' ' GLU . 1.6 mm -58.11 -47.52 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.706 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 33' ' ' LYS . 77.3 mt-30 -68.2 -26.03 65.52 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 30.1 mtpt -87.4 -10.96 50.64 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.761 0.791 . . . . 0.0 110.798 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.723 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -108.23 -12.79 21.02 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.741 172.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -64.05 -17.27 63.2 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -102.41 7.82 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.619 0.723 . . . . 0.0 109.911 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.723 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -87.22 119.6 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.875 173.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -99.66 -60.29 1.56 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.005 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 100.84 152.98 26.32 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.396 -176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 t -105.37 137.32 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 O-C-N 122.637 -0.331 . . . . 0.0 110.272 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 51' ' ' THR . 29.6 m -119.87 147.3 44.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.529 -177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 21.3 tt0 -127.93 133.8 49.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.746 HD12 HD12 ' A' ' 50' ' ' LEU . 18.5 mm -123.66 127.15 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.018 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.901 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 13.6 t -128.36 112.18 25.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 170.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.1 t-80 -108.48 114.11 27.68 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.766 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -111.05 107.24 16.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.334 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.65 -98.38 0.6 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.35 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' LEU . 10.6 mptt -97.45 -46.52 6.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.603 0.716 . . . . 0.0 110.392 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.017 ' HG2' HG23 ' A' ' 64' ' ' THR . 11.4 mtmt -73.07 136.88 45.02 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.414 -171.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.71 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 97.5 t -118.3 129.44 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.667 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.901 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 64.5 mttm -88.0 133.78 33.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.746 HD12 HD12 ' A' ' 41' ' ' ILE . 5.2 tp -128.96 106.83 9.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.308 0.575 . . . . 0.0 109.891 -174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' SER . 63.0 m -108.71 116.28 31.69 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.162 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HD23 ' A' ' 50' ' ' LEU . 1.6 mp -127.48 121.91 58.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.781 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 58' ' ' VAL . 6.6 m -92.65 119.75 32.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.843 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -101.49 97.28 7.76 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.81 -87.08 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.935 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 p -114.31 -32.47 5.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -89.61 151.93 21.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.001 0.429 . . . . 0.0 111.221 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 53' ' ' THR . 3.3 t -125.1 128.91 73.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.129 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.17 138.7 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -116.12 121.0 40.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.051 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -145.65 142.44 29.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.1 tt0 -123.68 144.94 49.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 23.9 p90 -140.37 142.41 35.53 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.213 -175.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 1.017 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.6 m -103.96 131.82 50.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.671 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -67.2 121.8 16.45 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.205 -179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.68 8.07 66.74 Favored Glycine 0 CA--C 1.5 -0.86 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 30.8 tt0 -129.19 144.71 51.31 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 82' ' ' VAL . 35.9 tt0 -70.8 110.98 5.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.281 0.563 . . . . 0.0 110.442 -175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.512 ' HB3' ' H ' ' A' ' 64' ' ' THR . 1.8 p -109.18 157.39 18.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.733 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 6.7 mt-10 -105.1 130.2 53.34 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.752 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -106.05 121.48 44.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.812 -175.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.781 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 41.1 tt0 -103.2 137.74 40.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.775 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.52 HG23 ' HE3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -107.39 177.5 4.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 172.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.3 tpp -72.5 -0.74 13.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.878 0.847 . . . . 0.0 110.045 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.4 p -88.82 -3.31 58.79 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.77 -11.82 38.65 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.276 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -81.57 118.77 23.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.001 0.905 . . . . 0.0 110.266 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 2.9 ttmp? -106.18 124.34 49.44 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.333 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 96' ' ' LYS . 8.6 p -115.37 128.47 72.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.005 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -80.22 127.16 32.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.712 0.768 . . . . 0.0 111.327 -178.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.15 161.46 40.16 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.973 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.6 t -107.75 119.9 58.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.206 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.743 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.96 129.78 66.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 111.326 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -145.16 166.99 23.83 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.219 -0.301 . . . . 0.0 110.256 171.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 3.0 mtt -79.29 136.12 36.94 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.57 145.17 24.65 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.01 7.45 1.18 Allowed Glycine 0 CA--C 1.507 -0.44 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -159.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -84.6 -67.12 0.82 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.84 0.32 . . . . 0.0 110.813 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.103 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 46.5 m-20 -150.12 -40.85 0.13 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -168.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.03 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 12.1 mtpt -149.1 -175.89 5.14 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.933 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.34 148.14 25.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -159.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 101' ' ' VAL . 64.4 t -111.04 139.87 32.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.561 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.743 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -135.59 117.98 15.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.391 0.615 . . . . 0.0 110.343 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.6 m -100.51 124.02 45.49 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.605 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.81 155.4 31.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.755 ' HG3' HG11 ' A' ' 79' ' ' VAL . 10.6 mttm 54.76 21.84 3.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.84 -9.25 57.17 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.656 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -97.21 147.61 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 117.066 0.433 . . . . 0.0 110.316 -176.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.702 ' HG3' HG23 ' A' ' 94' ' ' THR . 5.0 mptt -112.4 114.57 27.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.387 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m -119.5 124.6 46.84 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.725 -0.609 . . . . 0.0 112.229 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.724 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.86 139.31 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.012 0.525 . . . . 0.0 110.46 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.19 136.76 53.9 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.103 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.4 tt0 -127.77 137.02 52.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.612 0.57 . . . . 0.0 110.711 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.03 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 4.6 t80 -103.45 104.98 15.12 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.354 175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.38 98.48 6.77 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.444 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.06 -110.27 2.96 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.93 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.94 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 4.0 p30 -111.19 5.31 19.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.0 110.699 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.424 ' CG2' ' HD2' ' A' ' 125' ' ' LYS . 1.3 p -108.29 157.46 18.34 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.2 mt -118.14 147.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.796 HG23 ' HE3' ' A' ' 121' ' ' LYS . 14.0 m -119.85 128.51 53.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -115.6 117.69 31.02 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 101' ' ' VAL . 17.8 m -115.83 108.69 16.63 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 49.5 ttm -103.45 140.99 36.74 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.896 0.379 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.54 113.92 17.42 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -111.6 105.98 14.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.13 -93.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.434 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.19 -31.05 13.15 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.393 0.146 . . . . 0.0 111.393 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.815 HD12 ' HD1' ' A' ' 18' ' ' PHE . 4.5 pt -81.22 135.46 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 111.858 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.04 142.67 22.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.8 t80 -136.6 113.66 10.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.796 ' HE3' HG23 ' A' ' 110' ' ' THR . 1.1 tmtp? -111.99 143.81 42.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -137.27 142.25 41.96 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 59.2 t -118.83 121.01 65.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.908 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 34.3 m -101.48 155.82 17.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.019 0.437 . . . . 0.0 111.863 -174.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.62 ' HB2' ' HG3' ' A' ' 10' ' ' GLN . 45.8 tptt -127.68 145.01 51.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.94 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 39.1 ptt180 -61.73 137.76 58.27 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.009 172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 6' ' ' LYS . 1.6 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.987 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.877 0.37 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -88.48 113.35 23.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -134.15 -45.37 0.78 Allowed 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.142 -0.349 . . . . 0.0 110.846 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.99 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.8 p 58.66 112.49 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.939 0.876 . . . . 0.0 112.895 174.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.46 -167.09 39.72 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HG3' HD11 ' A' ' 127' ' ' ILE . 1.6 tppm? -94.82 138.59 32.42 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 117.299 0.549 . . . . 0.0 109.561 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -131.5 115.21 15.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.091 0.556 . . . . 0.0 109.924 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -99.7 129.14 45.8 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.103 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.7 t -62.21 138.53 22.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.891 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG3' ' H ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -115.8 -62.02 1.65 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.586 ' H ' ' HG3' ' A' ' 10' ' ' GLN . 8.1 m -96.98 154.95 17.0 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -151.33 156.28 40.44 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' LYS . 21.5 mm-40 -131.06 152.41 50.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.151 0.501 . . . . 0.0 111.301 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 15.3 m120 49.57 40.9 20.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.448 173.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -68.78 -35.61 77.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.563 0.697 . . . . 0.0 109.162 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.932 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -60.9 -57.09 28.91 Favored Pre-proline 0 C--O 1.205 -1.252 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.265 -176.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 8.6 Cg_endo -55.14 -41.21 80.81 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.892 1.728 . . . . 0.0 111.845 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 19.2 t80 -65.85 -51.65 57.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.826 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.815 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -70.17 -32.03 69.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 177.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' N ' HD11 ' A' ' 29' ' ' ILE . 13.9 mttm -59.96 -48.32 82.17 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.28 -18.12 62.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.335 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.815 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 33.6 mmm -80.22 -7.68 59.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.978 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.25 10.53 33.81 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.242 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.6 tp -89.55 130.55 43.01 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.567 0.699 . . . . 0.0 111.004 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' HD12 ' A' ' 24' ' ' LEU . 8.9 Cg_endo -69.81 150.43 67.92 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.399 2.733 . . . . 0.0 111.474 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.559 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 40.6 tt0 -52.72 -35.78 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.691 0.797 . . . . 0.0 112.299 -175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 t70 -64.76 -48.41 74.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.773 0.32 . . . . 0.0 110.633 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 28' ' ' LEU . 34.1 mt -71.81 -30.85 65.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.197 0.522 . . . . 0.0 109.675 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.6 mm -58.43 -49.47 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.175 175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -69.33 -32.04 70.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.868 0.366 . . . . 0.0 111.596 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 35.7 mtpt -76.13 -41.92 48.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.499 0.666 . . . . 0.0 110.235 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.848 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -73.39 -19.59 79.7 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.512 174.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -65.62 -12.92 57.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.096 0.474 . . . . 0.0 111.614 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.63 -12.38 31.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.73 0.776 . . . . 0.0 109.67 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.848 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -80.57 138.07 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.64 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.103 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 4.0 mptt -132.32 -82.99 0.49 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.875 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 114.96 168.96 15.87 Favored Glycine 0 C--N 1.308 -0.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.596 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 53' ' ' THR . 31.2 t -104.61 129.61 56.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.965 0.412 . . . . 0.0 110.729 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' THR . 2.0 m -117.39 149.63 40.21 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.529 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.614 ' HB2' ' HD3' ' A' ' 6' ' ' LYS . 37.1 tt0 -125.82 124.5 41.07 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 4' ' ' SER . 10.8 mm -119.25 114.92 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.044 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 4' ' ' SER . 0.9 OUTLIER -127.55 134.83 64.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -121.9 124.7 44.71 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -119.17 103.52 9.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.837 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 -101.75 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.825 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.8 mppt? -93.54 -46.37 7.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.354 0.597 . . . . 0.0 110.469 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 17.6 mttm -73.65 131.14 41.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.014 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 61.4 t -121.53 136.07 59.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.075 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.71 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 28.8 mtpp -88.13 127.35 35.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.9 mp -127.43 110.82 13.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.328 0.585 . . . . 0.0 111.178 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 39' ' ' SER . 36.5 m -110.57 115.3 29.37 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.4 mp -128.73 122.22 56.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.486 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 17.4 m -90.08 127.0 35.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.983 173.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -110.41 97.37 6.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 73.32 -64.37 1.71 Allowed Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.907 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.0 p -140.06 -42.14 0.43 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.663 0.268 . . . . 0.0 111.179 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 7.4 tptm -82.53 152.46 26.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.038 0.447 . . . . 0.0 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.3 t -122.52 123.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.622 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.81 121.15 53.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -119.37 119.77 34.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -147.68 136.76 22.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.692 0.282 . . . . 0.0 110.385 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 61.8 mp0 -102.65 143.47 32.28 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 167.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 31.1 p90 -139.47 144.08 37.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.316 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 37.5 m -98.64 129.8 45.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.087 0.47 . . . . 0.0 109.928 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.669 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.03 122.38 15.91 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.363 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.15 89.86 Favored Glycine 0 CA--C 1.501 -0.829 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.729 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 7.7 tp10 -124.11 143.05 50.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.952 -172.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 82' ' ' VAL . 28.2 tt0 -70.78 112.34 6.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 64' ' ' THR . 23.1 m -134.76 151.97 51.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.379 0.609 . . . . 0.0 109.885 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 19.1 mp0 -91.6 139.5 30.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.558 0.694 . . . . 0.0 112.115 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 1.9 mm? -106.2 117.51 34.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.328 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.6 tt0 -95.89 122.71 38.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 p -86.28 174.82 8.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.97 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 ptp -70.42 -2.0 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 p -97.08 -9.03 28.83 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.2 70.54 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.025 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -81.58 127.55 32.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.41 0.624 . . . . 0.0 110.437 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HG2' ' HB3' ' A' ' 70' ' ' GLU . 32.1 tttt -110.01 134.27 52.31 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.304 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.99 125.91 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 1.0 OUTLIER -66.68 129.31 39.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.537 1.161 . . . . 0.0 111.051 177.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.5 146.6 40.18 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.154 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 68' ' ' GLU . 53.5 t -101.68 112.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 O-C-N 122.04 -0.413 . . . . 0.0 110.463 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.3 123.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.552 0.692 . . . . 0.0 111.792 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -144.03 165.22 28.39 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 2.0 mtp -79.99 132.65 36.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -168.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -93.33 144.85 24.93 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.54 82.73 0.08 OUTLIER Glycine 0 CA--C 1.498 -1.012 0 O-C-N 123.982 0.801 . . . . 0.0 114.356 -165.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -159.07 -73.01 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.105 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.023 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 37.5 m-20 -149.95 -36.32 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -171.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.812 ' HE3' ' HB ' ' A' ' 102' ' ' THR . 2.8 mtpp -150.01 -175.35 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.6 mpt? -101.93 151.65 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.74 -159.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.7 t -112.98 137.15 46.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.785 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 t -132.69 122.83 25.22 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.209 0.528 . . . . 0.0 109.878 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -97.12 124.93 41.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.746 178.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -155.38 151.29 27.69 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 68.19 6.54 5.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 110.557 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.83 -3.52 85.98 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.415 -172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.1 pp -101.44 148.83 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 94' ' ' THR . 1.4 mptp? -105.53 117.19 33.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.075 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.5 t -115.28 116.37 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.919 0.39 . . . . 0.0 111.325 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -103.41 138.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.967 178.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.812 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -125.02 137.72 54.23 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.023 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 44.3 tt0 -129.85 137.13 50.27 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.825 0.703 . . . . 0.0 109.747 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.718 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.4 t80 -106.05 110.17 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -114.72 99.66 7.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.416 0.151 . . . . 0.0 111.345 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.35 -108.16 1.53 Allowed Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.334 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 6.0 p-10 -107.04 0.18 23.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 110.642 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -110.68 155.86 21.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.502 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 17.5 mt -119.57 139.03 48.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.714 0.292 . . . . 0.0 110.546 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.019 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -111.88 111.08 21.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.193 0.52 . . . . 0.0 110.428 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.2 t-20 -104.46 117.68 34.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.069 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.518 ' O ' HG13 ' A' ' 101' ' ' VAL . 10.1 m -117.38 114.0 22.91 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.912 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.938 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.4 ttm -103.21 139.17 39.03 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -127.53 121.36 30.48 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.721 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -116.58 106.02 13.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 170.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.09 -92.79 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.637 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.95 -35.18 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.074 0.149 . . . . 0.0 111.315 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 3.5 pt -77.05 132.83 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.0 111.563 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 143.68 21.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.624 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.938 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -125.88 137.39 53.73 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 1.019 ' HE2' HG22 ' A' ' 110' ' ' THR . 2.5 tmtp? -134.09 145.13 49.07 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.736 -0.786 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 52.6 mtt180 -138.59 146.62 42.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.697 168.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 19.2 t -117.3 118.55 58.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.8 m -98.29 147.59 24.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.969 0.414 . . . . 0.0 110.196 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 10' ' ' GLN . 5.6 tmtt? -118.76 142.69 47.46 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.269 -174.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 107' ' ' ASP . 0.4 OUTLIER -65.63 131.59 46.74 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.865 176.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.718 HD11 ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.707 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.793 0.33 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -104.17 95.04 5.7 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.43 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -101.54 45.56 0.96 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.694 0.759 . . . . 0.0 110.186 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 4.4 m -62.12 144.67 55.02 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.166 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -172.97 42.85 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HD3' ' HG3' ' A' ' 40' ' ' GLU . 4.0 tptt -103.69 139.92 38.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 117.481 0.64 . . . . 0.0 109.886 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 39' ' ' SER . 43.8 m-85 -131.16 114.86 15.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.573 0.701 . . . . 0.0 110.271 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' OE1' HG22 ' A' ' 38' ' ' VAL . 22.1 tp60 -92.5 113.02 25.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.171 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.865 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 12.6 t -61.06 135.59 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.96 -55.03 2.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.525 0.679 . . . . 0.0 110.582 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB3' ' HB ' ' A' ' 123' ' ' VAL . 1.7 t -95.31 147.24 23.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.168 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 72.9 mt-30 -151.41 159.06 44.42 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 168.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 10.0 pt-20 -138.33 161.01 38.03 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.369 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 56.37 34.15 23.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.106 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.9 -41.68 67.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.217 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.829 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -60.62 9.97 Favored Pre-proline 0 C--O 1.206 -1.236 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.382 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 18.9 Cg_endo -58.48 -28.08 84.22 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.753 1.635 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD1' HD12 ' A' ' 118' ' ' ILE . 54.6 t80 -71.8 -51.56 21.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.107 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.782 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.93 -32.35 71.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.736 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HG3' HG13 ' A' ' 29' ' ' ILE . 10.3 mttm -60.22 -48.26 82.5 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.17 -19.6 62.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.072 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.782 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 8.7 mmt -78.55 -11.65 59.97 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.058 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.24 7.56 22.74 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.512 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD12 ' HD2' ' A' ' 25' ' ' PRO . 12.4 tp -87.15 130.03 49.54 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.529 0.681 . . . . 0.0 110.875 -173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -70.65 145.11 51.09 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.322 2.682 . . . . 0.0 110.702 175.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 9.4 pt-20 -52.92 -29.49 28.93 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 7.8 t70 -64.81 -48.4 74.57 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.19 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 28' ' ' LEU . 36.0 mt -72.49 -31.48 65.42 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.829 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.69 -47.37 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.204 174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.1 mm100 -64.78 -31.79 73.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.305 0.574 . . . . 0.0 110.969 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 27' ' ' ASP . 31.1 mtpt -80.78 -36.34 31.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.664 0.745 . . . . 0.0 110.695 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.94 -10.63 80.56 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.654 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -15.51 40.89 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -95.86 -5.28 41.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.404 0.621 . . . . 0.0 109.797 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG23 ' HA2' ' A' ' 55' ' ' GLY . 22.9 mm -75.3 112.31 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.936 0.874 . . . . 0.0 112.087 -172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -166.9 1.24 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.717 -1.583 . . . . 0.0 108.28 169.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -156.0 166.91 33.16 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.582 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' OE1' ' A' ' 8' ' ' GLN . 39.3 t -102.24 119.28 50.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 51' ' ' THR . 49.5 m -103.73 148.03 26.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.147 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' HG3' ' HD3' ' A' ' 6' ' ' LYS . 24.7 tt0 -132.37 122.6 25.29 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' SER . 12.5 mm -116.5 114.37 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.802 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 21.8 t -121.6 111.15 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 3.5 t-160 -106.13 120.53 42.05 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.383 0.611 . . . . 0.0 110.933 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -121.98 107.38 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.526 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.64 -106.63 1.86 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.422 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 1.7 mptm? -97.73 -32.61 11.65 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.585 0.707 . . . . 0.0 109.508 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 16.8 mtmt -75.53 134.01 40.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.866 -173.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.665 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 46.2 t -123.11 129.33 75.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.792 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.802 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 56.8 mttp -88.32 138.71 31.19 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.366 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mp -128.47 115.92 18.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.229 0.537 . . . . 0.0 109.883 175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.8 m -108.34 115.79 30.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.5 mp -128.22 121.14 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.242 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.667 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 10.1 m -91.76 130.48 37.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.45 173.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.82 95.88 5.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 35' ' ' ILE . . . 67.66 -56.92 0.34 Allowed Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.675 0.61 . . . . 0.0 113.479 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 p -139.31 -46.86 0.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.723 -0.281 . . . . 0.0 111.696 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' LYS . 9.8 tppt? -83.97 152.07 24.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.836 0.35 . . . . 0.0 110.844 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 53' ' ' THR . 3.4 t -124.37 118.75 54.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -97.7 131.61 44.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.419 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 42.4 t-80 -118.06 120.0 36.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -143.48 145.31 32.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.948 0.404 . . . . 0.0 110.656 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' HG3' ' CG ' ' A' ' 49' ' ' LYS . 9.6 tt0 -122.78 145.61 48.26 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 24.1 p90 -140.01 146.56 39.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.87 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.4 m -103.65 133.37 48.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.288 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -68.69 120.0 13.98 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.09 8.68 83.48 Favored Glycine 0 CA--C 1.499 -0.944 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 34.4 tt0 -128.63 142.97 50.87 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.59 114.17 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 109.846 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -117.81 146.19 44.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.082 -178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 48.8 mt-10 -95.83 129.17 43.15 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.445 0.641 . . . . 0.0 111.359 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -102.43 129.82 49.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.644 -173.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.56 131.88 52.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.94 0.4 . . . . 0.0 110.684 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 p -94.58 179.01 5.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.429 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 tpp -78.94 -1.88 37.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.448 0.642 . . . . 0.0 110.203 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 p -94.75 -6.05 43.95 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.54 -28.8 7.86 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.553 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -72.57 116.16 12.7 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.706 0.765 . . . . 0.0 110.98 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' CG ' ' HB3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -101.29 142.91 32.02 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.704 177.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -124.95 137.64 56.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.638 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 9.3 ptpt -78.2 135.28 37.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.703 0.763 . . . . 0.0 111.002 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.02 150.76 40.03 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.891 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.69 115.31 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.12 -0.362 . . . . 0.0 111.084 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.689 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 11.8 p -112.26 130.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 111.645 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -145.79 166.4 26.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 167.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.5 mtp -79.77 135.28 36.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -169.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 88' ' ' ASP . 28.2 tt0 -91.8 145.76 24.3 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.6 78.94 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.782 0 CA-C-O 122.071 0.817 . . . . 0.0 113.926 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 86' ' ' GLU . 7.7 t0 -158.7 -74.07 0.08 Allowed 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 113.113 -1.543 . . . . 0.0 108.817 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.099 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 48.2 m-20 -154.32 -35.87 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -171.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.78 ' HB3' ' O ' ' A' ' 102' ' ' THR . 41.4 tttm -148.93 -175.45 4.96 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.114 -0.366 . . . . 0.0 111.18 -177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.4 mpt? -101.88 151.77 21.7 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.137 0.575 . . . . 0.0 110.656 -159.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.811 HG22 ' HB ' ' A' ' 101' ' ' VAL . 68.3 t -114.37 137.39 47.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.428 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 7.7 t -134.89 140.28 45.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' HG3' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -114.56 124.41 51.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.962 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.3 p90 -152.37 148.24 27.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt 50.59 26.19 2.33 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.88 0.472 . . . . 0.0 112.025 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.29 -0.11 89.23 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.012 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.8 pp -105.47 148.37 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.108 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.473 ' HG3' HG22 ' A' ' 94' ' ' THR . 0.0 OUTLIER -112.67 128.57 56.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -131.39 133.47 45.29 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.844 -0.535 . . . . 0.0 112.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.811 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -110.17 140.33 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.59 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.78 ' O ' ' HB3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -123.56 137.27 54.79 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.099 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 31.6 tt0 -129.42 134.02 47.64 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 123.483 0.489 . . . . 0.0 110.465 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.53 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.0 OUTLIER -97.77 106.51 18.83 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.0 178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.61 98.9 7.54 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.59 -108.04 2.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.57 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 1.142 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 6.5 m-20 -110.4 0.1 17.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.39 0.614 . . . . 0.0 109.63 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 125' ' ' LYS . 1.2 p -110.88 157.52 19.76 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.765 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.34 123.94 72.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.331 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 11.9 m -100.26 115.35 29.71 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 13.4 t-20 -101.22 121.04 41.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.1 m -117.23 114.85 24.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.924 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 22.5 ttt -102.43 139.56 37.87 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.83 -0.544 . . . . 0.0 109.657 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 112.97 16.32 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.732 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -112.97 106.68 15.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 172.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.46 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 O-C-N 123.407 0.442 . . . . 0.0 113.439 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -104.95 -23.67 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.742 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.4 pt -82.92 127.76 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.163 0.506 . . . . 0.0 110.903 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.39 141.95 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.924 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 46.2 t80 -128.78 139.24 52.28 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.697 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -131.61 147.18 52.5 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.853 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 28.1 mtt180 -136.77 142.75 42.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.48 ' CG2' ' HE2' ' A' ' 121' ' ' LYS . 92.1 t -117.61 115.87 49.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.865 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.2 m -101.18 131.23 47.26 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.525 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.0 OUTLIER -115.34 143.94 44.51 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 1.142 ' HD3' ' HB3' ' A' ' 107' ' ' ASP . 32.4 ptt180 -66.5 137.04 56.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.311 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.454 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.76 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.371 0.605 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.26 110.69 22.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.888 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -101.51 44.73 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.188 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.6 m -69.7 126.05 28.57 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.582 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.87 179.03 45.19 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.635 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -99.23 138.04 36.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.709 0.755 . . . . 0.0 109.549 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CD2' HG13 ' A' ' 109' ' ' ILE . 59.5 m-85 -126.54 117.97 23.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.968 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.2 pt20 -97.54 123.86 41.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.955 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.2 t -64.68 135.07 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.162 0.506 . . . . 0.0 110.955 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -109.62 -70.14 0.83 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.504 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -89.8 150.11 22.4 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -175.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -150.16 156.89 42.44 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 170.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -121.4 148.01 44.96 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.444 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 54.59 41.16 32.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 124.547 1.154 . . . . 0.0 111.802 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 23.9 t80 -72.25 -40.87 67.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.808 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.861 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.9 mt-10 -57.63 -59.0 14.36 Favored Pre-proline 0 C--O 1.209 -1.056 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.322 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 16.4 Cg_endo -57.09 -28.14 77.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.8 1.666 . . . . 0.0 111.9 -174.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.773 ' HD1' HD12 ' A' ' 118' ' ' ILE . 44.4 t80 -72.84 -52.35 15.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.411 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.819 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.11 -31.74 70.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.595 0.236 . . . . 0.0 110.593 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' HG3' HG13 ' A' ' 29' ' ' ILE . 25.3 mttt -59.56 -47.99 83.39 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.07 -21.14 62.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.819 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 53.2 mmm -79.74 -2.54 43.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.301 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.83 7.41 38.86 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.482 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 29' ' ' ILE . 13.4 tp -89.69 130.52 42.83 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.487 0.66 . . . . 0.0 111.084 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HG2' HD12 ' A' ' 28' ' ' LEU . 9.7 Cg_endo -68.21 142.9 57.03 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.202 2.601 . . . . 0.0 110.685 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.0 tt0 -53.5 -31.55 46.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.47 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.05 -45.91 83.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.774 0.321 . . . . 0.0 110.382 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -71.69 -30.99 66.29 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.634 0.731 . . . . 0.0 109.286 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mm -58.04 -47.53 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.401 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 26.8 mt-30 -67.17 -24.57 65.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.886 0.374 . . . . 0.0 111.615 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -60.54 2.33 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.123 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.679 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -58.16 -25.04 56.45 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 113.852 -1.522 . . . . 0.0 113.004 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 39.9 pttt -64.41 -10.38 24.55 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -95.95 -4.87 42.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.786 0.803 . . . . 0.0 109.189 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.679 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.5 mp -88.36 137.14 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.795 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.955 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -127.62 -35.67 2.11 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.824 0.821 . . . . 0.0 109.426 177.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 86.9 164.19 39.71 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.602 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.81 131.4 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 51' ' ' THR . 4.0 m -120.91 148.11 44.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.14 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 32.1 tt0 -125.86 134.89 51.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 4' ' ' SER . 24.8 mm -124.24 115.57 45.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.077 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.869 ' HB ' ' HD2' ' A' ' 49' ' ' LYS . 29.1 t -123.16 111.38 29.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 48' ' ' VAL . 5.3 t-160 -102.7 117.86 35.59 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.238 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -121.12 111.03 16.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.611 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 -102.54 0.93 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.194 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -102.54 -42.29 5.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 110.727 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.3 mtmt -73.1 136.99 44.97 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.78 0.8 . . . . 0.0 110.887 -174.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 1.028 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 39.6 t -121.61 135.59 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.917 177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.869 ' HD2' ' HB ' ' A' ' 42' ' ' VAL . 60.2 mttm -87.68 120.37 28.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.339 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.5 mp -114.87 106.56 14.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.349 0.595 . . . . 0.0 109.956 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' SER . 27.7 m -110.26 114.92 28.78 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.5 mp -126.31 121.15 58.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 58' ' ' VAL . 3.5 m -96.46 114.44 26.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.01 98.33 8.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.91 -91.33 0.18 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.824 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 p -114.45 -20.96 10.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -98.83 156.37 16.9 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 110.692 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 53' ' ' THR . 9.7 t -124.58 126.98 72.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.447 -176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 74' ' ' MET . 64.0 mt -106.24 123.24 60.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.798 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -119.33 119.29 33.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.85 137.34 31.37 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 45.0 mt-10 -123.13 120.23 32.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.028 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -123.7 146.25 48.39 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.032 -169.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.4 m -98.26 125.54 43.39 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.464 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -61.25 117.25 5.37 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.723 -179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.6 3.24 88.85 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.045 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 33.2 tt0 -126.13 145.13 50.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -70.33 123.02 20.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.496 0.665 . . . . 0.0 111.112 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -133.58 152.7 51.94 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.404 -177.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.855 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mp0 -92.22 127.87 37.85 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.098 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -104.28 123.28 47.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.288 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 38.6 tt0 -110.74 128.22 55.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.454 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.6 p -89.27 166.23 13.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 59' ' ' ILE . 21.8 ptm -65.07 -1.85 2.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.358 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.9 p -95.77 -22.13 17.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 116.7 -17.7 13.39 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.043 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 8.0 mp0 -79.35 121.05 24.65 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 122.128 0.966 . . . . 0.0 112.104 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 32.3 ttmt -112.22 135.36 52.99 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.111 -1.858 . . . . 0.0 110.582 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.5 p -133.3 122.74 45.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.102 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.855 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 5.1 ptpt -63.74 116.65 5.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 122.143 0.973 . . . . 0.0 111.195 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.29 161.7 37.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.143 -1.39 . . . . 0.0 111.088 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.63 125.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 111.469 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 ' CD2' ' A' ' 63' ' ' PHE . 15.0 p -112.96 126.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.896 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 85' ' ' MET . 32.7 ttpt -144.97 168.26 20.69 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.289 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -83.0 133.61 35.09 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -164.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 88' ' ' ASP . 27.4 tt0 -93.94 145.47 24.61 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.42 78.36 0.06 OUTLIER Glycine 0 CA--C 1.502 -0.747 0 O-C-N 124.088 0.868 . . . . 0.0 114.046 -169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 86' ' ' GLU . 6.2 t70 -159.4 -72.19 0.08 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 113.332 -1.434 . . . . 0.0 109.213 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 38.7 m-20 -153.41 -35.7 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -171.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 103' ' ' GLU . 26.1 mttt -150.81 -175.77 5.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.002 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.9 mpp? -102.59 150.13 23.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.601 . . . . 0.0 111.033 -159.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 101' ' ' VAL . 71.3 t -116.12 137.48 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.438 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.651 ' HB ' HG23 ' A' ' 83' ' ' VAL . 8.0 t -137.33 133.32 34.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.263 177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 99' ' ' LYS . 1.2 p -102.25 129.54 48.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.395 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -151.65 140.57 21.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.32 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' H ' HG11 ' A' ' 79' ' ' VAL . 51.3 mtpt 57.05 22.69 7.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.589 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.3 -0.89 89.26 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.643 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.91 148.31 5.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -113.69 114.91 27.04 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -174.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -116.01 117.03 29.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.656 0.265 . . . . 0.0 111.333 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.84 138.86 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.85 137.06 53.73 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 0.8 OUTLIER -128.32 142.7 51.05 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.394 0.434 . . . . 0.0 110.232 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.688 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 41.3 t80 -100.37 112.84 25.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.832 0.825 . . . . 0.0 111.113 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -106.55 158.66 16.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -45.49 99.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.485 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 61.17 16.41 7.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.867 0.867 . . . . 0.0 112.03 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 125' ' ' LYS . 0.7 OUTLIER -133.23 157.9 44.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.757 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 8.7 mt -119.5 135.29 60.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 O-C-N 121.797 -0.564 . . . . 0.0 110.564 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -108.62 110.34 21.77 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.96 117.27 33.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.992 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.4 m -115.43 110.37 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.082 172.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.5 ttm -104.3 139.47 39.25 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.848 0.356 . . . . 0.0 110.363 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -127.53 116.63 20.66 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.242 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -109.16 105.03 14.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.54 -93.07 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 O-C-N 123.657 0.598 . . . . 0.0 113.969 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -93.95 -31.42 14.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.952 0.406 . . . . 0.0 111.202 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.773 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.2 pt -89.74 135.3 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.896 0.379 . . . . 0.0 111.429 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.69 142.05 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -136.03 114.92 12.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.941 0.4 . . . . 0.0 110.013 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.6 tmtp? -114.71 142.05 47.01 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.644 ' HB3' HG11 ' A' ' 9' ' ' VAL . 49.1 mtm180 -138.07 145.71 42.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 169.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.7 t -117.06 117.09 54.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.878 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 4.5 m -99.28 139.06 35.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.805 0.336 . . . . 0.0 110.431 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 108' ' ' THR . 1.3 tmmt? -122.67 144.49 49.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.656 0.741 . . . . 0.0 109.447 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -68.1 146.06 53.83 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.894 -170.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.709 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.113 0.483 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -104.61 94.64 5.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.095 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -62.01 -66.11 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 60.2 p 54.41 108.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.073 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.8 178.77 45.88 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.896 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.3 tppt? -94.47 139.09 31.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.103 0.452 . . . . 0.0 110.126 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.696 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 73.9 m-85 -131.03 116.39 17.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.112 0.482 . . . . 0.0 110.065 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HB3' ' CD1' ' A' ' 127' ' ' ILE . 1.3 pt20 -91.12 127.16 36.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 13.7 t -64.63 125.73 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.1 0 CA-C-O 122.228 1.013 . . . . 0.0 110.199 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.573 ' O ' HG12 ' A' ' 9' ' ' VAL . 16.3 mt-30 -102.32 -104.85 0.27 Allowed 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 113.28 -1.782 . . . . 0.0 106.608 162.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 123' ' ' VAL . 0.7 OUTLIER -76.56 124.5 27.7 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.22 -1.55 . . . . 0.0 111.835 -148.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -126.82 154.24 44.57 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.276 -176.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.19 160.69 37.89 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.226 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 58.5 31.39 20.95 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 124.808 1.317 . . . . 0.0 111.627 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.6 t80 -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.941 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -58.33 -59.59 12.95 Favored Pre-proline 0 C--O 1.205 -1.245 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.912 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 11.8 Cg_endo -56.87 -28.87 79.32 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.908 1.739 . . . . 0.0 112.55 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' CD1' HD12 ' A' ' 118' ' ' ILE . 44.0 t80 -73.98 -51.19 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.289 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.797 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -69.12 -32.15 71.34 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.645 176.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HG3' HG13 ' A' ' 29' ' ' ILE . 19.8 mttt -59.97 -48.01 83.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.8 62.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.307 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.797 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 30.5 mtp -80.16 -8.85 59.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.214 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.56 11.77 24.4 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.451 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.86 127.93 50.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.701 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -69.74 152.75 69.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.521 2.814 . . . . 0.0 111.791 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -51.8 -41.09 61.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.88 -43.6 95.57 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.798 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.582 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 30.7 mt -73.54 -31.88 63.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.523 0.677 . . . . 0.0 110.1 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.941 HD12 ' HA ' ' A' ' 16' ' ' GLU . 2.7 mm -58.27 -45.69 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.954 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.576 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 78.6 mt-30 -63.46 -23.71 67.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.168 0.509 . . . . 0.0 111.485 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.9 mtpp -90.55 -12.81 35.99 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.461 0.648 . . . . 0.0 110.703 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -114.23 -20.96 5.73 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.217 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.753 ' HA ' ' CD1' ' A' ' 15' ' ' PHE . 10.0 ptmm? -57.64 -27.55 62.92 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 2.6 p-10 -103.64 -2.39 26.67 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.157 -174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.485 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.1 mp -79.18 137.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.551 0.691 . . . . 0.0 111.948 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -130.99 -87.36 0.49 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.099 175.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 128.19 -174.68 18.73 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.432 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' H ' ' HB ' ' A' ' 53' ' ' THR . 44.6 t -104.24 130.81 54.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 0.0 110.643 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 52' ' ' ILE . 5.4 m -115.37 149.66 37.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.863 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.739 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 29.7 tt0 -129.37 136.24 49.74 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.1 mm -124.28 114.51 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.62 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.722 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 2.9 t -123.04 137.26 57.08 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.444 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.7 t-80 -121.09 122.28 39.7 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.028 -1.045 . . . . 0.0 111.856 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.9 109.7 15.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.051 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.38 -103.44 0.81 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.486 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.01 -41.25 6.86 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.411 0.624 . . . . 0.0 110.396 171.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.75 ' HG2' HG23 ' A' ' 64' ' ' THR . 3.9 mtmp? -72.12 134.05 45.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.743 -173.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HE1' ' A' ' 63' ' ' PHE . 63.1 t -116.68 134.31 60.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.891 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.79 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 12.7 mtpp -87.48 116.98 25.97 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.4 mp -111.28 110.77 21.41 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' SER . 13.2 m -110.7 114.57 28.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' LEU . 3.8 mp -128.07 121.3 55.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.477 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 5.3 m -87.79 125.79 34.64 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 97.0 m-85 -110.45 96.85 6.45 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -62.33 0.36 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.91 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -144.14 -33.33 0.41 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 74' ' ' MET . 8.7 tppt? -84.36 152.79 23.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 122.045 -0.409 . . . . 0.0 110.341 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.64 118.85 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.811 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 74' ' ' MET . 75.4 mt -99.31 120.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -120.13 118.79 31.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -148.05 137.66 22.37 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.233 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.79 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 25.5 mp0 -99.44 134.8 41.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.851 ' HE1' ' HB ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -118.8 142.45 47.7 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.977 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -91.23 126.73 36.41 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' CE ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -61.31 115.63 3.99 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -171.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 84' ' ' LYS . . . 65.49 24.25 70.81 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.6 tp10 -134.03 143.79 48.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.266 -0.967 . . . . 0.0 108.437 -177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -71.21 123.74 22.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.322 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.9 p -124.48 158.75 32.1 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.793 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 35.2 mt-10 -99.78 125.06 45.63 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.651 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -103.66 123.79 47.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.685 -174.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.748 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . 35.4 tt0 -101.43 129.81 47.53 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -90.5 -173.75 3.88 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.072 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.578 ' HG3' ' HG2' ' A' ' 57' ' ' LYS . 50.3 ttm -73.02 -7.59 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.152 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.2 p -95.06 -11.63 27.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.317 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.08 -20.14 50.68 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.138 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.55 126.5 30.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.525 0.679 . . . . 0.0 110.41 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.748 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 37.0 ttmt -109.4 139.02 44.89 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.249 -175.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 95' ' ' PHE . 7.2 p -129.72 137.76 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.048 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 16.7 mtmm -63.82 119.16 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.505 0.669 . . . . 0.0 110.882 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 95' ' ' PHE . . . -139.42 144.95 38.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.917 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.28 119.08 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 122.124 -0.36 . . . . 0.0 110.952 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.755 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 p -102.17 131.22 50.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.705 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -143.06 162.06 36.52 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -82.43 107.0 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.871 -167.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.603 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 25.9 tt0 -126.88 143.57 51.23 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.313 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.51 0.3 40.19 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -168.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 t70 78.82 -39.12 0.23 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 113.398 -1.401 . . . . 0.0 112.429 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.026 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 51.8 m-20 -100.4 -30.27 11.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.564 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.997 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -148.46 -175.94 5.11 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.997 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 0.6 OUTLIER -107.72 151.6 25.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.369 0.604 . . . . 0.0 112.346 -160.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.761 HG22 ' HB ' ' A' ' 101' ' ' VAL . 74.6 t -107.83 134.79 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.42 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.755 ' HB ' HG23 ' A' ' 83' ' ' VAL . 6.9 t -133.88 127.49 32.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.1 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 99' ' ' LYS . 16.5 m -102.88 125.22 49.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 54.5 p90 -151.67 146.59 25.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 48.4 mtpt 54.38 22.44 3.79 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 111.718 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.14 -8.21 79.06 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.536 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 115' ' ' LEU . 1.2 pp -97.99 146.74 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.005 0.431 . . . . 0.0 109.87 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -115.1 114.07 24.84 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.992 -172.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 8.5 t -114.21 124.28 51.65 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.785 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.761 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.3 m -103.06 138.63 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.968 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.633 ' HB ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -127.72 137.13 52.36 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 175.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.026 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.3 tt0 -124.89 126.95 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.814 0.446 . . . . 0.0 110.867 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.997 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.7 t80 -101.58 102.96 13.77 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.386 -0.196 . . . . 0.0 110.517 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -115.53 97.83 6.38 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.488 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.85 -102.33 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.184 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 126' ' ' ARG . 12.2 m-20 -106.32 2.0 26.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.858 0.361 . . . . 0.0 110.773 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -124.49 156.15 37.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 120.926 0.393 . . . . 0.0 110.459 -175.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 7.7 mt -129.19 137.45 57.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 122.739 0.416 . . . . 0.0 109.962 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.499 ' CG2' ' HE3' ' A' ' 121' ' ' LYS . 2.6 m -109.73 115.06 29.16 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 21.4 t-20 -105.28 116.65 32.3 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 101' ' ' VAL . 17.1 m -118.6 118.31 31.32 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.937 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 47.5 ttm -102.72 140.58 36.81 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.811 -0.556 . . . . 0.0 109.599 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.3 113.69 16.62 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.245 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -110.07 106.31 15.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 42.42 -93.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.648 0.593 . . . . 0.0 113.876 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.86 -32.46 13.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 18' ' ' PHE . 6.2 pt -82.87 132.06 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 111.822 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.22 144.14 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.533 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.937 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 42.5 t80 -132.4 140.36 48.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.4 144.08 46.36 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.69 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 12.5 mtp180 -138.87 145.15 39.61 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 109.078 170.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' SER . 75.1 t -120.37 113.93 42.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.37 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.6 m -99.67 122.06 42.13 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.805 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 4.6 tmtm? -117.4 147.36 42.73 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 24.5 mtp180 -64.48 144.95 56.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.653 -170.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.487 ' H ' HG12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.151 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.813 172.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 121.03 0.443 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -78.97 89.6 4.75 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -71.46 74.87 0.77 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.155 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.875 ' HB2' HG13 ' A' ' 42' ' ' VAL . 2.1 t -107.92 142.01 38.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.597 0.713 . . . . 0.0 111.224 172.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.28 -167.68 32.42 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.02 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.747 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 1.6 tptt -122.28 136.58 54.93 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.711 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 40.2 m-85 -128.86 116.17 19.02 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.36 0.6 . . . . 0.0 110.547 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -96.71 124.58 40.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.865 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 17.6 t -61.67 135.21 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.31 0.576 . . . . 0.0 111.888 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 16.2 mm100 -106.42 -69.65 0.82 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.468 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 8.2 m -99.73 152.53 19.99 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.442 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 15.8 mt-30 -150.9 157.38 42.83 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -131.72 154.26 49.2 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.935 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 52.41 35.09 16.52 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.763 1.289 . . . . 0.0 111.94 166.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 33' ' ' LYS . 21.7 t80 -72.29 -41.06 67.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.324 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp0 -59.12 -58.14 21.75 Favored Pre-proline 0 C--O 1.211 -0.928 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.604 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 19.2 Cg_endo -60.59 -30.94 91.6 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.655 1.57 . . . . 0.0 111.592 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.748 ' CD1' HD12 ' A' ' 118' ' ' ILE . 40.1 t80 -72.62 -51.36 19.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.879 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 4.0 mmt -69.23 -31.4 69.94 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.996 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 29' ' ' ILE . 11.1 mttm -58.64 -49.02 79.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' HD13 ' A' ' 118' ' ' ILE . . . -72.82 -17.15 61.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.59 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.879 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 39.2 mtp -79.48 -13.57 59.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.845 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.62 9.49 19.03 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.529 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.47 129.89 47.56 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.449 0.642 . . . . 0.0 110.408 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.52 144.87 56.7 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.124 2.549 . . . . 0.0 110.655 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 10.9 pt-20 -53.09 -30.06 34.08 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.456 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -66.06 -45.92 79.62 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.393 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 39.1 mt -74.25 -32.64 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mm -58.82 -47.94 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.321 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 14.2 mm100 -63.8 -24.66 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.913 0.387 . . . . 0.0 111.051 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 19.4 mtpp -83.74 -61.06 1.93 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.892 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -60.93 -20.67 57.88 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.998 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 4.4 pttp -61.57 -14.47 30.32 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -103.35 -11.45 17.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.19 0.519 . . . . 0.0 110.643 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.892 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.0 mp -77.52 138.55 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-O 121.967 0.889 . . . . 0.0 112.42 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 6.6 mtmp? -137.47 -154.42 0.54 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.724 -1.58 . . . . 0.0 108.74 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 178.46 -169.39 41.01 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.075 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.89 129.94 56.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 120.883 0.373 . . . . 0.0 110.805 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.9 p -116.78 117.07 28.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.377 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.747 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 27.9 tt0 -98.47 131.47 44.69 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.793 ' O ' ' HA ' ' A' ' 4' ' ' SER . 16.8 mm -124.31 119.88 57.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.475 -174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 4' ' ' SER . 47.6 t -127.43 108.99 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB2' HG22 ' A' ' 48' ' ' VAL . 5.5 t-80 -99.53 111.04 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.06 106.0 14.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.525 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.43 -92.07 0.22 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.765 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -107.12 -45.75 4.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.534 0.683 . . . . 0.0 110.967 173.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.824 ' HG2' HG23 ' A' ' 64' ' ' THR . 14.4 mttm -72.83 133.28 44.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.21 -171.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.684 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 94.5 t -109.82 137.1 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.166 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.722 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 7.7 mttp -85.46 127.89 34.55 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.983 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -129.97 117.26 19.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.161 0.981 . . . . 0.0 110.609 174.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 39' ' ' SER . 33.2 m -124.41 114.3 19.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.234 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 50' ' ' LEU . 1.4 mt -121.66 121.64 64.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.674 -170.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.639 HG23 HG22 ' A' ' 58' ' ' VAL . 2.3 m -96.94 119.36 35.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.46 97.8 7.5 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.16 -81.44 0.13 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.3 p -119.86 -32.61 4.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 57' ' ' LYS . 7.0 tptt -87.78 151.28 23.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 122.143 -0.348 . . . . 0.0 110.63 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' THR . 6.1 t -124.41 125.1 69.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.091 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.8 mm -104.54 123.38 58.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.981 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -118.85 119.9 35.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -147.29 139.67 24.63 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 44.1 mt-10 -123.1 129.87 52.03 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.684 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.0 p90 -133.93 146.96 51.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.813 -167.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.824 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.7 m -103.19 132.18 49.65 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.291 0.567 . . . . 0.0 110.914 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -66.05 118.96 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.781 -177.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 84' ' ' LYS . . . 72.64 11.34 77.22 Favored Glycine 0 CA--C 1.496 -1.139 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 24.5 tt0 -131.55 144.31 51.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 82' ' ' VAL . 27.8 tt0 -70.4 119.09 14.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.104 0.478 . . . . 0.0 110.566 -172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -135.64 149.13 49.23 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.072 0.939 . . . . 0.0 110.972 -176.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.4 mp0 -94.78 128.36 41.44 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.041 -169.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' C ' ' HG3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -100.94 126.42 47.58 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.066 -176.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 6.9 tt0 -113.44 118.54 34.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.279 -168.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 p -89.62 -177.96 5.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 112.137 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.4 ttm -72.0 -3.6 23.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.413 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.7 p -96.44 -6.95 36.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.714 0.768 . . . . 0.0 109.481 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.97 -27.26 5.56 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.468 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -78.94 114.15 17.64 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.201 1.0 . . . . 0.0 111.615 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.848 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . 30.2 ttpt -109.64 141.81 41.67 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.295 -1.775 . . . . 0.0 111.799 -171.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG11 ' H ' ' A' ' 96' ' ' LYS . 11.3 p -121.1 136.19 58.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.415 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HG2' ' OE2' ' A' ' 70' ' ' GLU . 33.6 mtmt -65.04 122.35 16.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.546 0.689 . . . . 0.0 111.139 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.65 159.58 41.93 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.797 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 68' ' ' GLU . 44.0 t -110.74 118.14 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 121.807 -0.558 . . . . 0.0 111.284 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.1 p -111.84 128.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.29 0.567 . . . . 0.0 111.625 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' HD13 ' A' ' 65' ' ' LEU . 5.9 tttp -144.33 166.15 25.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 171.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 5.4 mtp -78.92 132.44 36.74 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -168.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -91.11 147.82 22.8 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.94 76.98 0.11 Allowed Glycine 0 CA--C 1.496 -1.112 0 O-C-N 124.461 1.1 . . . . 0.0 113.85 -167.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' C ' HD22 ' A' ' 89' ' ' ASN . 1.2 t70 -162.02 -74.68 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.594 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.047 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -146.53 -42.93 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -166.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.845 ' HG2' ' H ' ' A' ' 91' ' ' MET . 65.7 tttt -147.02 -176.8 5.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.59 0.356 . . . . 0.0 111.504 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.076 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -98.7 151.61 20.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.372 0.606 . . . . 0.0 110.59 -162.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 101' ' ' VAL . 43.3 t -113.65 138.5 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.746 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.774 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.6 t -137.37 120.5 16.71 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.67 HG23 ' HG3' ' A' ' 99' ' ' LYS . 10.9 m -98.96 126.95 44.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -153.35 144.56 23.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' H ' HG11 ' A' ' 79' ' ' VAL . 45.3 mtpt 54.24 25.64 6.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.947 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.1 59.0 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.907 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.5 147.82 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 122.463 -0.434 . . . . 0.0 110.443 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 94' ' ' THR . 4.9 mptt -106.93 132.14 53.22 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 t -131.22 120.53 23.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.129 -0.357 . . . . 0.0 111.569 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.809 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -104.96 138.23 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.486 0.66 . . . . 0.0 110.237 176.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.762 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -121.84 138.05 54.53 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.047 ' HG3' ' HB2' ' A' ' 89' ' ' ASN . 33.3 tt0 -128.94 135.84 49.57 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.808 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 1.5 t80 -109.42 107.43 17.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.001 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -111.9 99.3 8.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.521 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.33 -106.03 0.94 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.095 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.727 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 2.5 p30 -109.92 2.58 19.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.562 . . . . 0.0 110.361 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 p -109.85 158.1 18.52 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.89 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.08 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 3.5 mt -118.45 140.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 ' HE2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -118.99 110.86 17.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.313 0.578 . . . . 0.0 110.271 177.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 2.1 t-20 -101.34 120.6 40.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.918 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.4 m -117.17 111.92 20.12 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.681 -0.807 . . . . 0.0 108.992 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.911 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 48.8 ttm -102.15 141.89 34.28 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.39 113.01 15.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.028 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -108.3 106.49 16.66 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 43.62 -95.27 0.01 OUTLIER Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.446 0.466 . . . . 0.0 113.338 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.71 -33.34 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.543 0.211 . . . . 0.0 111.324 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.748 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.6 pt -78.21 134.36 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.107 0.48 . . . . 0.0 111.446 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -111.44 142.45 23.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 18.9 t80 -128.93 137.13 51.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.921 ' HE2' HG22 ' A' ' 110' ' ' THR . 1.7 tmtp? -135.71 139.17 43.44 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.449 -0.782 . . . . 0.0 110.676 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 42.2 mtm180 -137.72 145.57 42.67 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 55.2 t -118.25 118.5 58.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 1.08 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 4.7 m -98.5 152.69 19.27 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 122.751 0.42 . . . . 0.0 111.229 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -129.81 143.18 50.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.727 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 22.0 mtt180 -66.94 130.08 41.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.408 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -102.56 89.72 3.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.625 0.726 . . . . 0.0 110.013 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -77.29 -56.8 4.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.496 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.802 ' HB2' HG13 ' A' ' 42' ' ' VAL . 89.1 p 53.03 107.28 0.01 OUTLIER 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.011 0.925 . . . . 0.0 112.649 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.89 -173.06 45.03 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.742 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.02 139.66 30.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.967 0.383 . . . . 0.0 110.142 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -127.81 119.79 26.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.398 0.618 . . . . 0.0 109.625 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -95.94 119.8 35.08 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.367 -178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 15.0 t -63.35 133.3 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.05 0.452 . . . . 0.0 110.793 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 125' ' ' LYS . 14.6 mm100 -108.29 -60.94 1.66 Allowed 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 7.0 m -103.55 152.43 21.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.594 ' CD ' ' HG2' ' A' ' 36' ' ' LYS . 17.7 mt-30 -152.0 157.83 42.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.847 ' HG2' ' HB3' ' A' ' 121' ' ' LYS . 12.0 pt-20 -138.68 160.43 39.67 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.979 0.419 . . . . 0.0 110.853 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 52.28 31.68 9.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.145 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -71.97 -41.63 67.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.736 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -59.85 -60.66 9.89 Favored Pre-proline 0 C--O 1.205 -1.273 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.188 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' LYS . 13.3 Cg_endo -56.58 -28.04 72.48 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.899 1.733 . . . . 0.0 112.188 -174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.713 ' HD1' HD12 ' A' ' 118' ' ' ILE . 56.7 t80 -70.5 -51.13 31.12 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.09 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.816 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 28.7 mtt -69.24 -32.5 71.77 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 120.628 0.252 . . . . 0.0 110.704 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 9.2 mttm -60.51 -46.97 88.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -25.3 64.29 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.802 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.816 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 11.2 mmt -78.42 -1.09 31.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.16 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.78 6.86 34.56 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.378 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 29' ' ' ILE . 6.6 tp -85.71 131.95 45.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.871 0.843 . . . . 0.0 111.793 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.48 144.79 32.75 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.796 2.997 . . . . 0.0 110.314 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.682 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -52.9 -33.21 49.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.21 -42.1 84.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.739 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 50.4 mt -74.25 -32.83 63.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 109.609 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.7 mm -58.88 -47.55 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.309 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.611 HE21 HG22 ' A' ' 29' ' ' ILE . 23.2 mm-40 -64.58 -22.07 66.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.91 0.386 . . . . 0.0 111.235 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 17.0 mtpp -80.02 -51.34 9.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.279 0.562 . . . . 0.0 109.627 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -68.82 -18.95 72.92 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.136 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 2.7 tttt -59.67 -16.81 29.21 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.821 0.848 . . . . 0.0 113.077 -173.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -98.56 -14.03 20.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.61 0.719 . . . . 0.0 110.395 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.4 mp -80.41 137.63 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.733 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 38.7 mtmt -139.94 -32.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.201 -175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . 77.39 169.49 32.45 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.948 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 8' ' ' GLN . 39.5 t -105.54 132.19 53.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.644 0.259 . . . . 0.0 110.354 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 54.2 m -114.06 149.44 35.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.58 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 32.4 tt0 -130.87 128.6 40.93 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.3 mm -124.96 115.5 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.784 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.802 HG13 ' HB2' ' A' ' 4' ' ' SER . 12.7 t -115.61 111.99 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.512 ' CD2' HG22 ' A' ' 48' ' ' VAL . 3.9 t-80 -103.04 113.99 27.91 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.295 0.569 . . . . 0.0 110.639 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.46 105.06 11.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.443 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.93 -99.93 0.46 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.208 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 4.3 mptp? -99.52 -45.6 5.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.738 . . . . 0.0 110.335 174.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.844 ' HG2' HG23 ' A' ' 64' ' ' THR . 18.4 mtmt -72.25 135.58 46.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.027 -173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.696 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 54.0 t -123.83 126.66 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.187 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 13.7 mtpp -89.92 131.3 35.91 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.822 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.14 133.38 56.06 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.983 0.897 . . . . 0.0 111.549 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 26.1 m -125.83 116.33 21.39 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.98 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.833 HG13 HD12 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -127.27 121.32 57.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.835 -173.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.671 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.1 m -103.55 121.34 42.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 m-85 -101.86 96.77 7.27 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 174.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.48 -66.19 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.444 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.7 p -136.17 -39.36 0.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' LYS . 8.0 tppt? -84.38 151.37 24.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG22 HG23 ' A' ' 53' ' ' THR . 3.8 t -123.2 139.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.424 -175.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -110.57 138.38 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -118.56 122.59 43.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.052 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -149.53 143.98 25.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 49' ' ' LYS . 11.8 tt0 -124.81 140.41 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.696 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.5 p90 -141.27 149.65 41.57 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.05 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.844 HG23 ' HG2' ' A' ' 47' ' ' LYS . 7.5 m -106.33 134.75 48.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.945 0.402 . . . . 0.0 110.766 -174.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.783 HD21 ' HG2' ' A' ' 91' ' ' MET . 0.1 OUTLIER -68.3 120.99 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.016 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.26 8.93 66.73 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 32.8 tt0 -127.78 146.43 50.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.211 -0.494 . . . . 0.0 109.699 -175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 82' ' ' VAL . 3.6 tm-20 -68.81 121.08 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.688 0.756 . . . . 0.0 110.142 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 p -132.48 158.43 42.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.696 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 25.6 mt-10 -104.33 144.56 31.46 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.499 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -103.45 124.32 48.52 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.815 -176.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -99.65 126.9 45.75 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.175 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -90.72 174.93 7.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.545 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -72.6 -2.31 19.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.405 0.622 . . . . 0.0 109.755 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 p -94.47 -17.05 22.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.637 0.732 . . . . 0.0 109.217 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -20.89 42.25 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.908 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.67 118.16 16.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.443 1.116 . . . . 0.0 110.815 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CD ' ' HB2' ' A' ' 70' ' ' GLU . 10.8 ttmm -110.03 122.25 47.16 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.824 -176.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.14 132.62 66.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.793 0.33 . . . . 0.0 111.869 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.753 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 22.7 mtmt -63.09 121.04 12.63 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.533 0.683 . . . . 0.0 111.58 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.39 145.11 27.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.133 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 68' ' ' GLU . 47.2 t -104.72 117.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p -108.28 126.12 64.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.669 0.747 . . . . 0.0 111.411 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 65' ' ' LEU . 4.7 ttmt -143.49 165.61 27.09 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 12.6 mtm -79.81 108.21 13.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.62 -161.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 22.4 tt0 -125.16 144.13 50.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.313 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.2 2.98 54.37 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -166.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 t70 79.24 -35.2 0.16 Allowed 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 113.518 -1.341 . . . . 0.0 112.702 167.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.085 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 64.1 m-20 -104.7 -30.92 9.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.741 ' HB3' ' C ' ' A' ' 102' ' ' THR . 32.8 tttt -147.68 -179.69 7.06 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.048 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.3 mpp? -100.84 151.47 21.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.696 0.76 . . . . 0.0 112.25 -162.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 101' ' ' VAL . 47.5 t -108.56 135.98 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.314 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 3.9 t -131.03 117.05 18.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.454 0.645 . . . . 0.0 110.136 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 123.98 41.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.09 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 98' ' ' ILE . 55.6 p90 -155.18 150.26 26.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -174.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 96' ' ' LYS . 46.6 mtpt 53.47 21.52 2.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.81 -2.29 88.28 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.739 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.4 pp -101.59 148.83 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -110.87 131.18 55.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -131.91 117.77 18.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.367 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.875 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -107.3 140.76 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.741 ' C ' ' HB3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -127.58 139.81 52.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.085 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 tt0 -128.93 134.94 48.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.597 0.237 . . . . 0.0 110.591 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.614 ' H ' ' HB3' ' A' ' 89' ' ' ASN . 8.9 t80 -100.79 106.96 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.43 98.0 6.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.441 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.09 -99.82 0.18 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.461 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.919 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 10.6 p-10 -116.35 -3.3 11.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.6 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.433 ' CG2' ' HD3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -104.81 158.32 16.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.354 -178.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.158 ' HB ' ' HB2' ' A' ' 124' ' ' SER . 4.3 mt -119.48 146.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -118.93 110.68 17.43 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.053 0.454 . . . . 0.0 109.953 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 2.6 t-20 -101.06 119.33 38.59 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.62 ' O ' HG13 ' A' ' 101' ' ' VAL . 27.2 m -116.67 111.55 19.99 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.2 ttt -102.58 140.13 37.26 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 m -127.18 120.31 28.48 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -114.11 106.11 13.99 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 170.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.75 -97.36 0.01 OUTLIER Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.349 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.51 -35.64 14.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.713 HD12 ' HD1' ' A' ' 18' ' ' PHE . 5.3 pt -75.95 123.69 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.116 0.484 . . . . 0.0 111.152 -176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -105.04 142.96 17.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 54.7 t80 -137.34 138.92 40.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.684 -172.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.847 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -133.48 150.77 51.72 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.559 -0.713 . . . . 0.0 111.701 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.473 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 34.1 mtt180 -138.22 146.76 43.01 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.838 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 43.2 t -117.81 118.51 58.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 1.158 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 25.7 m -98.85 151.09 21.21 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 108' ' ' THR . 33.6 tptt -126.32 149.21 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.657 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.919 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 11.9 ptm180 -69.65 148.86 48.75 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.323 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.568 HD13 ' HB2' ' A' ' 8' ' ' GLN . 1.1 pt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.2 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' HB3' ' HE1' ' A' ' 43' ' ' HIS . 67.5 mtt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.801 0.334 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.55 89.68 6.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.15 0.5 . . . . 0.0 110.901 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -98.11 38.73 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.591 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.769 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 1.4 m -67.1 137.01 56.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.267 0.556 . . . . 0.0 111.839 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.75 -170.81 36.01 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -106.35 136.6 45.8 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 117.833 0.816 . . . . 0.0 109.956 179.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 126' ' ' ARG . 51.4 m-85 -128.25 116.59 20.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -94.73 121.13 35.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.91 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 21.4 t -59.95 130.8 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.656 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -109.94 -60.56 1.77 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.046 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 123' ' ' VAL . 2.0 m -94.69 149.68 21.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 122' ' ' ARG . 13.0 mt-30 -150.88 156.09 40.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 167.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -136.8 152.81 50.71 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 HD22 HG13 ' A' ' 119' ' ' VAL . 34.7 m-20 50.4 39.69 21.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.452 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 35.4 t80 -72.13 -39.26 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.774 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.866 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.1 mt-10 -59.35 -59.31 14.25 Favored Pre-proline 0 C--O 1.206 -1.199 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.68 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 25.1 Cg_endo -58.18 -28.83 85.42 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.666 1.577 . . . . 0.0 111.865 -173.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HD1' HD12 ' A' ' 118' ' ' ILE . 40.5 t80 -73.89 -52.1 14.03 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.434 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.854 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.85 -32.48 72.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.06 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HG3' HG13 ' A' ' 29' ' ' ILE . 23.4 mttt -59.53 -48.79 80.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.6 -19.4 62.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.528 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.854 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 42.5 mmm -80.12 -5.36 55.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.171 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.64 12.27 30.91 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.435 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD22 ' SD ' ' A' ' 19' ' ' MET . 13.1 tp -90.39 129.23 46.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.441 0.639 . . . . 0.0 110.579 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.34 150.09 75.85 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.152 2.568 . . . . 0.0 111.291 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -52.41 -36.95 55.48 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.296 0.372 . . . . 0.0 111.869 -178.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.81 -43.45 88.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.989 0.423 . . . . 0.0 110.802 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 29.2 mt -73.55 -31.53 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.89 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.3 mm -58.13 -47.69 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.107 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.83 -28.93 69.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -80.21 -56.88 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.493 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.878 ' HA2' HD13 ' A' ' 35' ' ' ILE . . . -63.0 -15.54 56.25 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.754 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 14.0 tttt -56.81 -28.82 62.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.414 0.686 . . . . 0.0 112.471 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 -4.83 40.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.456 0.646 . . . . 0.0 110.465 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.878 HD13 ' HA2' ' A' ' 32' ' ' GLY . 1.9 mp -80.1 129.32 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-O 122.135 0.969 . . . . 0.0 112.464 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -140.67 135.04 31.24 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.42 -1.718 . . . . 0.0 107.521 174.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.22 -170.2 33.42 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.365 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.638 HG22 ' HG2' ' A' ' 8' ' ' GLN . 49.0 t -103.99 128.68 57.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.5 p -115.98 115.87 26.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.214 0.53 . . . . 0.0 110.647 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 23.2 tt0 -99.07 127.56 45.03 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 4' ' ' SER . 7.5 mm -124.39 116.02 46.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.436 -171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 4' ' ' SER . 38.7 t -125.95 111.48 27.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' HE1' ' HB3' ' A' ' 1' ' ' MET . 4.4 t-80 -105.99 114.76 29.09 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.239 0.542 . . . . 0.0 111.016 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -119.65 112.7 19.63 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.528 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.68 -105.06 1.19 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.363 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' CA ' ' HB2' ' A' ' 65' ' ' LEU . 2.6 mptm? -94.65 -45.38 7.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.498 0.666 . . . . 0.0 110.671 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG2' HG23 ' A' ' 64' ' ' THR . 27.7 mttt -74.34 135.87 42.51 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.459 -172.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.651 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 47.3 t -119.88 135.12 61.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.773 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 2.0 ttmt -87.42 134.07 33.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 2.4 mp -129.78 106.9 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 110.372 173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 39' ' ' SER . 26.7 m -108.25 113.94 27.42 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.26 129.54 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.956 0.408 . . . . 0.0 111.755 -170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.768 HG23 HG22 ' A' ' 58' ' ' VAL . 6.5 m -101.54 124.34 47.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD13 ' A' ' 59' ' ' ILE . 90.1 m-85 -110.6 97.75 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 171.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.97 -93.66 0.1 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -95.21 -48.22 6.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -86.87 154.27 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.646 0.736 . . . . 0.0 111.757 -173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.768 HG22 HG23 ' A' ' 53' ' ' THR . 9.3 t -125.0 118.44 53.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.842 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 74' ' ' MET . 3.7 mp -95.53 121.97 46.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -119.62 119.43 33.72 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -153.91 151.03 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 49' ' ' LYS . 3.8 mp0 -114.78 144.25 43.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.651 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 16.1 p90 -131.08 147.38 52.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.891 HG23 ' HG2' ' A' ' 47' ' ' LYS . 6.4 m -105.52 130.08 53.66 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.143 0.497 . . . . 0.0 110.816 -171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.565 HD11 ' HE2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -64.51 123.59 19.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.785 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.5 14.59 72.26 Favored Glycine 0 CA--C 1.497 -1.094 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.689 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 9.7 tp10 -132.43 141.78 48.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.623 -172.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.2 tt0 -72.28 111.45 7.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.399 0.618 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -113.92 145.79 40.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.628 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.922 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 24.0 mt-10 -92.89 124.4 36.85 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.173 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 95' ' ' PHE . 35.4 mt -108.64 142.94 38.38 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.936 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -119.86 135.35 54.91 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.889 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.655 HG21 ' HD3' ' A' ' 96' ' ' LYS . 73.5 p -98.62 -175.1 2.98 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 111.991 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.779 ' HB3' HD11 ' A' ' 59' ' ' ILE . 4.2 ppp? -76.82 -2.11 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.27 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 p -92.93 -21.79 19.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.91 -18.78 36.5 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.488 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.89 125.52 29.48 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.687 0.756 . . . . 0.0 111.581 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.922 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 1.5 tmmm? -110.95 141.26 44.63 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.848 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 96' ' ' LYS . 7.6 p -132.42 137.57 54.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.294 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 44.1 mtmt -63.71 124.25 20.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.183 0.516 . . . . 0.0 111.092 170.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.83 160.09 40.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.057 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' GLU . 26.8 t -119.8 120.0 61.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 O-C-N 122.12 -0.362 . . . . 0.0 111.021 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.817 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.3 p -111.97 124.31 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.442 0.639 . . . . 0.0 111.252 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -144.24 168.54 19.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.139 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.781 ' HA ' ' HG3' ' A' ' 91' ' ' MET . 8.5 mtm -78.86 135.31 36.99 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.251 0.548 . . . . 0.0 111.09 -161.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -100.18 141.75 32.59 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.06 76.74 0.72 Allowed Glycine 0 CA--C 1.496 -1.147 0 CA-C-O 122.138 0.854 . . . . 0.0 114.11 -166.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.0 -76.22 0.1 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.437 -1.381 . . . . 0.0 109.525 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.754 ' CB ' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -147.69 -36.73 0.21 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -166.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.93 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 1.7 mtpt -149.03 178.5 8.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG3' ' HA ' ' A' ' 85' ' ' MET . 1.8 mpt? -102.76 151.55 22.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.267 -166.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 101' ' ' VAL . 55.1 t -110.27 140.32 29.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.115 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.817 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 t -134.1 133.23 40.86 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 110.418 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 99' ' ' LYS . 14.3 m -109.99 124.91 52.26 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.228 177.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.686 ' O ' HG13 ' A' ' 98' ' ' ILE . 54.5 p90 -147.54 144.99 28.91 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' H ' HG11 ' A' ' 79' ' ' VAL . 27.4 mtpp 55.07 16.32 1.51 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.4 0.619 . . . . 0.0 111.032 -169.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.64 -8.31 76.86 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.335 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 95' ' ' PHE . 1.9 pp -94.57 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 94' ' ' THR . 0.0 OUTLIER -109.79 126.12 53.44 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -170.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 92' ' ' VAL . 33.8 m -130.07 131.06 45.62 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.259 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -101.59 138.68 25.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.472 0.653 . . . . 0.0 110.44 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.2 m -119.04 137.44 53.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.911 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -130.26 140.2 50.71 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 122.461 0.304 . . . . 0.0 110.987 176.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.93 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -114.31 107.36 15.47 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.621 177.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.479 ' C ' HD22 ' A' ' 105' ' ' ASN . 0.2 OUTLIER -113.54 98.19 6.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 109.972 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.87 -105.89 1.32 Allowed Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.787 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.2 -5.02 19.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 0.0 110.006 -174.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.8 m -120.32 155.09 34.03 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.641 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 mt -117.68 139.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.846 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 4.4 m -108.67 123.05 48.36 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.06 113.62 26.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.1 m -117.17 112.58 21.03 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.47 ' HE1' ' CZ ' ' A' ' 18' ' ' PHE . 22.9 ttt -104.27 139.46 39.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.149 0.5 . . . . 0.0 110.216 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.86 113.2 16.26 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.588 178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -110.29 105.99 15.23 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.09 -97.87 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.392 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.2 -30.28 13.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.832 HD12 ' HD1' ' A' ' 18' ' ' PHE . 12.3 pt -80.22 130.68 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.085 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 14' ' ' ASN . 3.3 p -110.69 141.49 25.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.746 ' HE2' HH11 ' A' ' 122' ' ' ARG . 64.9 t80 -136.67 137.44 40.03 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.569 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 110' ' ' THR . 0.0 OUTLIER -133.91 144.47 48.88 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.121 -175.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.746 HH11 ' HE2' ' A' ' 120' ' ' TYR . 19.0 mtm-85 -137.54 144.36 42.07 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.2 t -119.14 116.38 50.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 2.4 m -101.81 125.06 48.4 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-O 120.707 0.289 . . . . 0.0 110.298 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -116.04 146.55 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.054 0.454 . . . . 0.0 110.28 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.598 ' HG3' ' CE2' ' A' ' 7' ' ' TYR . 5.6 mtp180 -58.55 135.13 57.25 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.528 -173.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.977 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.015 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB2' ' HE1' ' A' ' 3' ' ' PHE . 9.3 ptp . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.578 0.704 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -106.0 127.57 53.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 91.5 m-85 -120.88 -63.87 1.3 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.696 ' HB2' HG13 ' A' ' 42' ' ' VAL . 27.2 p 62.16 121.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.071 0.949 . . . . 0.0 112.549 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 -169.7 36.04 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 127' ' ' ILE . 3.0 tptm -98.82 142.61 30.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.414 ' CG ' HD11 ' A' ' 109' ' ' ILE . 37.8 m-85 -133.64 116.66 16.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB3' HD13 ' A' ' 127' ' ' ILE . 1.8 pt20 -91.29 126.69 36.45 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.797 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 21.6 t -64.35 142.91 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG3' ' CG ' ' A' ' 125' ' ' LYS . 16.8 mm-40 -122.21 -63.11 1.32 Allowed 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.36 150.69 22.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HG2' ' HG2' ' A' ' 122' ' ' ARG . 13.3 mt-30 -149.19 157.69 43.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.61 146.53 51.97 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.452 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 29.2 m-80 55.45 38.06 29.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.177 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 38.9 t80 -70.37 -41.72 72.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.85 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 mt-10 -60.01 -59.04 15.12 Favored Pre-proline 0 C--O 1.208 -1.095 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.603 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 16' ' ' GLU . 27.9 Cg_endo -58.49 -28.5 85.69 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.862 1.708 . . . . 0.0 112.056 -174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 118' ' ' ILE . 43.3 t80 -73.48 -51.09 18.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.231 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.792 ' HA ' ' HB2' ' A' ' 22' ' ' MET . 0.1 OUTLIER -68.9 -32.3 71.85 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.541 176.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.501 ' HG3' HG13 ' A' ' 29' ' ' ILE . 9.3 mttm -59.79 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -17.87 62.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.39 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.792 ' HB2' ' HA ' ' A' ' 19' ' ' MET . 15.6 mtp -79.03 -10.15 59.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.06 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.98 12.24 26.29 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.043 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.82 129.06 49.97 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.462 0.648 . . . . 0.0 110.591 -176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.97 143.46 49.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.233 2.622 . . . . 0.0 110.087 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 25.3 tt0 -54.45 -28.96 47.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -65.27 -43.32 91.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.466 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 28' ' ' LEU . 33.9 mt -74.19 -31.82 62.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 109.92 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 16' ' ' GLU . 3.5 mm -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.065 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 66.4 mm-40 -66.0 -26.3 67.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.844 0.354 . . . . 0.0 111.227 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 20.6 mtpp -79.26 -52.32 8.29 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.356 0.598 . . . . 0.0 110.184 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -25.8 66.96 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.733 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -61.38 -23.82 66.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.353 0.661 . . . . 0.0 112.777 -176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.84 -18.57 30.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.05 0.929 . . . . 0.0 109.279 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.689 HG21 ' HA2' ' A' ' 55' ' ' GLY . 2.2 mp -83.53 117.56 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.046 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -101.24 -32.69 10.39 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.44 172.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.11 167.37 41.28 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.963 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HE2' ' A' ' 6' ' ' LYS . 46.0 t -105.98 135.81 42.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 51' ' ' THR . 41.7 m -116.76 148.07 41.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 19.8 tt0 -122.44 127.01 49.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 4' ' ' SER . 9.0 mm -124.86 113.49 36.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 4' ' ' SER . 35.1 t -127.85 113.54 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 48' ' ' VAL . 4.1 t-160 -106.23 110.74 23.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.713 0.768 . . . . 0.0 110.979 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.97 106.75 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.973 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.84 -92.89 0.06 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.991 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.77 -46.05 5.27 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.657 0.742 . . . . 0.0 110.658 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.777 ' HG2' HG23 ' A' ' 64' ' ' THR . 25.9 mtmm -72.29 133.43 45.01 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.37 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.716 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 44.9 t -119.37 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.738 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.9 ttmt -89.41 136.49 33.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.1 mp -128.53 115.52 18.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.996 0.427 . . . . 0.0 110.698 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.9 m -110.66 116.02 30.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' LEU . 2.2 mp -128.57 129.43 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.351 -173.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.685 HG23 HG22 ' A' ' 58' ' ' VAL . 3.1 m -97.06 120.01 36.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.437 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.17 98.14 7.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.689 ' HA2' HG21 ' A' ' 35' ' ' ILE . . . 66.05 -108.8 2.55 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.323 -0.941 . . . . 0.0 110.918 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -100.62 -9.38 21.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.799 0.333 . . . . 0.0 111.123 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.3 140.73 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.873 0.368 . . . . 0.0 110.038 -177.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 53' ' ' THR . 16.7 t -125.81 118.42 51.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.229 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.424 HG22 HD22 ' A' ' 61' ' ' ASN . 62.0 mt -109.47 125.05 66.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.279 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.509 ' HD2' ' OG1' ' A' ' 51' ' ' THR . 40.3 t-80 -118.16 119.56 35.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.012 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.424 HD22 HG22 ' A' ' 59' ' ' ILE . 25.2 m-80 -143.22 144.72 32.27 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 120.779 0.323 . . . . 0.0 110.201 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -122.86 141.11 52.23 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.716 ' CE1' ' HB ' ' A' ' 48' ' ' VAL . 19.1 p90 -140.13 147.95 40.95 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.953 -169.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.777 HG23 ' HG2' ' A' ' 47' ' ' LYS . 5.3 m -100.79 133.42 45.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.077 0.465 . . . . 0.0 110.637 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -67.2 122.34 17.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.417 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.35 -3.11 42.1 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.836 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 37.2 tt0 -116.93 143.65 45.46 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.594 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.18 115.02 8.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.391 0.615 . . . . 0.0 109.857 -177.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 157.94 30.42 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.901 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.91 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 62.5 mt-10 -100.39 139.49 35.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.139 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.33 130.66 53.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.063 -174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -115.45 114.94 25.72 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.8 p -146.52 -2.11 0.68 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.717 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttm -75.19 -3.76 34.86 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 p 74.54 27.96 1.31 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.905 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.83 -63.5 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.09 -2.323 . . . . 0.0 112.564 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.81 113.44 13.28 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.798 0.809 . . . . 0.0 111.806 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.91 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -96.93 144.33 26.96 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.633 -178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.63 138.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 6.5 mtmp? -64.98 130.29 42.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.307 0.575 . . . . 0.0 111.773 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.35 161.75 38.89 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.116 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 68' ' ' GLU . 27.0 t -119.13 117.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 122.146 -0.346 . . . . 0.0 111.448 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.805 ' HB ' ' HB ' ' A' ' 93' ' ' THR . 7.4 p -112.52 129.25 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.677 ' HG2' HD13 ' A' ' 65' ' ' LEU . 1.1 tmmm? -144.83 165.89 26.81 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 171.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 91' ' ' MET . 6.1 mtt -80.31 135.5 36.22 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.069 0.461 . . . . 0.0 109.899 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -96.44 144.82 26.21 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.97 79.87 0.13 Allowed Glycine 0 CA--C 1.502 -0.771 0 O-C-N 123.912 0.758 . . . . 0.0 114.523 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.03 -69.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.726 -1.237 . . . . 0.0 109.214 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 1.037 ' HB2' ' HG2' ' A' ' 103' ' ' GLU . 5.2 m120 -147.74 -41.98 0.17 Allowed 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.937 ' HG3' ' HB2' ' A' ' 104' ' ' PHE . 2.3 mtpt -148.01 -175.38 4.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.06 0.457 . . . . 0.0 112.189 -176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' ' HA ' ' A' ' 85' ' ' MET . 2.5 mpt? -101.08 151.87 21.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.494 -160.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.794 HG22 ' HB ' ' A' ' 101' ' ' VAL . 72.6 t -113.08 136.02 50.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.712 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.805 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 4.9 t -131.79 125.26 31.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 110.379 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.7 m -104.12 126.16 51.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.351 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.701 ' O ' HG13 ' A' ' 98' ' ' ILE . 51.4 p90 -153.26 146.12 24.42 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 64.97 5.92 3.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.261 0.553 . . . . 0.0 110.915 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.76 -16.25 57.7 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.257 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 95' ' ' PHE . 2.0 pp -94.46 146.43 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.189 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 1.076 ' HG2' ' HB ' ' A' ' 114' ' ' THR . 0.0 OUTLIER -108.77 127.38 53.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.775 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -131.05 126.56 36.19 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.656 -0.653 . . . . 0.0 112.349 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -103.61 138.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.921 ' HB ' ' HE2' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -123.65 136.68 54.62 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 1.037 ' HG2' ' HB2' ' A' ' 89' ' ' ASN . 3.0 tt0 -125.38 128.09 47.61 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 123.981 0.801 . . . . 0.0 109.557 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.937 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 1.2 t80 -101.74 121.22 41.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.717 0.77 . . . . 0.0 111.673 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.8 OUTLIER -113.36 158.85 20.07 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.213 -178.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.04 104.92 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.298 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 64.41 7.93 3.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.75 0.82 . . . . 0.0 112.678 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.84 159.18 41.43 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 122.625 0.37 . . . . 0.0 110.549 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 123' ' ' VAL . 7.8 mt -132.39 140.24 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.545 -0.722 . . . . 0.0 111.201 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 103' ' ' GLU . 1.8 m -111.45 119.08 37.6 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 23.1 t-20 -105.44 119.81 40.03 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.2 m -117.16 110.4 18.12 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.825 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.487 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 18.5 ttt -102.78 139.75 37.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.113 0.483 . . . . 0.0 109.732 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 1.076 ' HB ' ' HG2' ' A' ' 99' ' ' LYS . 1.4 m -126.54 128.82 47.47 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.813 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -127.45 107.06 9.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 172.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 49.33 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 O-C-N 123.444 0.465 . . . . 0.0 113.595 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -101.96 -28.96 12.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.265 0.226 . . . . 0.0 111.467 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 18' ' ' PHE . 7.1 pt -82.16 132.67 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 111.626 -176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.66 143.27 21.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 113' ' ' MET . 45.9 t80 -135.61 137.46 41.94 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -173.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -135.4 149.3 49.61 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.54 -0.725 . . . . 0.0 111.395 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.576 ' HG2' ' HG2' ' A' ' 12' ' ' GLN . 8.3 mtt180 -137.15 145.37 43.69 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 168.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 44.2 t -118.74 117.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.7 m -106.89 156.03 19.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.379 0.609 . . . . 0.0 111.573 -173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.441 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 18.9 mmtt -120.09 149.06 42.8 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.04 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -71.51 121.35 18.53 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.145 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.604 HD11 ' CG ' ' A' ' 6' ' ' LYS . 6.9 pt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.084 171.669 . . . . . . . . 1 1 . 1 stop_ save_